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ABSTRACT 
Autism has been declared an urgent public health concern by the U.S. government and an 
epidemic by some advocacy groups. Determining autism’s diagnostic criteria, prevalence, and 
causes have been challenging. It is important to examine how the U.S. media have contributed to 
the public’s understanding of autism. Previous research found that British media coverage of the 
theory that vaccines cause autism was shown to contribute to the decline of vaccination rates in 
Britain (Lewis & Speers, 2003). This study examined U.S. television news media coverage using 
an agenda-setting theory and media framing perspective. A content analysis was conducted of 
national television evening news broadcasts airing on ABC, CBS, and NBC from 1994, when 
autism was first recognized as a spectrum disorder through April 2010, the time of this study. 
Specifically, this study examined the saliency of autism stories and how autism was framed in 
terms of prevalence and causes.  
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
Throughout the evolving understanding of autism, it seems the disorder has always held a 
fascination for the public and those who have researched it. Autism or autism spectrum disorders 
(ASDs), as many in the scientific community now describe it, are a “group of developmental 
disabilities characterized by atypical development in socialization, communication, and behavior. 
ASDs typically are apparent before age 3 years, with associated impairments affecting multiple 
areas of a person's life” (Centers for Disease Control and Prevention, 2009a, np). It has been said 
that very little about autism is ever noncontroversial (Donnellan, 1985) and it is not surprising 
that many advocacy groups have adopted a puzzle as the symbol for autism given that 
determining the diagnosis criteria, the prevalence, as well as causes and risk factors have proven 
to be challenging. Determining the diagnostic criteria has especially been difficult. In fact, the 
recognition of autism as a spectrum disorder did not occur until 1994 when the American 
Psychiatric Association included Asperger syndrome and other developmental disorders in the 
fourth edition of its Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), the 
standard by which mental disorders are diagnosed in the United States.  
The lack of established diagnostic criteria for autism or ASDs has meant inconsistent 
diagnoses and affected how and whether children received services. For many years, researchers 
believed the prevalence of autism was four to five per 10,000 children (Centers for Disease 
Control and Prevention, 2007a), but research published in 1999 suggested that it may be actually 
somewhere between 30 to 60 per 10,000 children or around 1 in 166 (Fombonne, 1999). Some 
researchers and parent groups in the U.S. believed this data was evidence that autism was an 
epidemic (Fombonne, 1999). In 2007, the Centers for Disease Control and Prevention (CDC) 
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published the first prevalence rates from multiple sites in the U.S. using the diagnostic criteria 
from the Diagnostic and Statistical Manual of Mental Disorders-IV -Text Revision. They 
reported that 1 in 150 children had an ASD diagnosis in 2002 (CDC, 2007b). In 2009, the CDC 
published prevalence rates reporting that 1 in 110 children were diagnosed with an ASD in 2006 
(CDC, 2009a), up from their previous estimates. With the release of these prevalence rates, CDC 
has called ASDs “an urgent public health concern” (CDC, 2009a, p.1), but has not been able to 
confirm whether prevalence rates are truly increasing or if the rates have increased due to the 
changes in diagnostic criteria over the years. Nevertheless, the largest autism advocacy groups 
began referring to autism as an epidemic and argued that it deserved to be recognized as a public 
health priority in terms of research and services (Autism Society of America, 2007; Autism 
Speaks, 2007).  
Perhaps the most puzzling and controversial issue surrounding autism has been the 
suggested link between vaccines and autism. In 1998, a Lancet journal article presented findings 
that demonstrated a link between the measles virus and autism, suggesting that the vaccine for 
measles, mumps, and rubella (MMR) caused autism. At a press conference from the Royal Free 
Hospital in London, the study’s main author, Andrew Wakefield, posited that giving children 
individual MMR vaccines in three separate doses at annual intervals would be a safe alternative 
to the current MMR vaccine. It should be noted that 10 of Wakefield's 13 co-authors disavowed 
the findings of the study in 2004, his claims in the article have been refuted by a substantial body 
of research, and Lancet retracted the article in 2010 (DeNoon, 2010). However, after 
Wakefield’s study was published in 1998, MMR vaccination rates in Britain fell from a high of 
92% to below 80% in 2003 (Lewis & Speers, 2003). Attempts to explain the fall of vaccination 
rates point to the media’s coverage of Wakefield’s findings. One focus group study found that 
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“the media reports about MMR had affected most parents’ immunization decisions, except for 
those few who were already committed to their views” (Lewis & Speers, 2003, p. 914). Research 
on the subsequent MMR media coverage in Britain found a direct relationship between the level 
of media coverage and public concern (Lewis & Speers, 2003). Another study suggested that 
perceived safety of the MMR vaccine fell after periods of media coverage in October 2000 and 
March 2001, but rose again once media coverage declined (Lewis & Speers, 2003).  
The MMR vaccine and autism media coverage in Britain and the subsequent decline in 
vaccination rates demonstrate the power of the mass media to contribute to potential public 
health crises. So, could that happen in the United States (U.S.)—or has it already happened?  The 
measles vaccine first became available in the mid-1960s and before that time, measles caused 
450 reported deaths and 4,000 cases of encephalitis annually in the U.S. Endemic measles 
transmission was eliminated in the U.S. after the vaccine became available (CDC, 2008). 
However, between January and July 2008, 131 measles cases were reported to the CDC 
compared with an average of 63 cases per year between 2000 and 2007 (CDC, 2008). According 
to the CDC (2008), the number of measles cases reported between January and July 2008 was 
the highest year-to-date since 1996. Among those measles cases reported during the first 7 
months of 2008, 76% occurred in people younger than 20 years of age and 91% were 
unvaccinated or of unknown vaccination status. So the idea of a return of measles due to vaccine 
refusal is of great concern to U.S. government agencies such as the CDC who are charged with 
protecting the public’s health. In March 2010, a Pediatrics article reported that 1 in 4 surveyed 
parents in the U.S. in January 2009 believed that some vaccines cause autism (Freed, Clark, 
Butchart, Singer, & Davis, 2010) despite overwhelming consensus in the medical and scientific 
community that vaccines do not cause autism (Institute of Medicine, 2004). Parents were not 
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asked about their media viewing habits or if seeing or hearing specific media stories influenced 
their beliefs about autism. However, 81% of parents who believed that some vaccines cause 
autism reported that they had heard or read about problems with the MMR vaccine (Freed et al., 
2010).  
Current mass communication literature focuses on analyses of print media coverage of 
the debate over whether vaccines cause autism. However, only limited research is available 
about how other autism-related topics (e.g., prevalence rates and potential causes of autism other 
than vaccines) are covered by the news media. Furthermore, no research is available on 
broadcast media coverage of autism in the U.S. The influence of television has been studied 
since its invention and is an important medium to examine. A recent analysis of health 
information-seeking behaviors revealed that passive media outlets, such as television and radio, 
were more likely to be the primary sources of health information for the individual who was 
categorized as less health oriented (Dutta-Bergman, 2004). Furthermore, a recent survey 
conducted by Pew (2008) showed that 29% of respondents reported watching nightly network 
news. Respondents equally reported watching either NBC Nightly News or ABC’s World News 
Tonight (14% each) and 8% reported watching the CBS Evening News. Television remains a 
source of health information and television evening news continues to be watched among one-
third of those surveyed in the U.S., thus, it deserves to be analyzed in terms of autism media 
coverage. Therefore, this study attempted to fill in some of the gaps in autism media coverage 
research by providing a content analysis of autism-related stories featured in national television 
evening news broadcasts airing on ABC, CBS, and NBC. The purpose of the analysis was to 
investigate how television news media framed autism causes and prevalence and contributed to 
the public discourse on these issues from 1994, when autism was first recognized as a spectrum 
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of disorders in the DSM-IV, through April 2010, the time of this study. This analysis will 
hopefully lay the foundation for additional research to understand what, if any, role U.S. mass 
media plays in influencing beliefs, attitudes, intentions, or behaviors of audiences in relation to 
autism.  
To better understand autism’s newsworthiness, it is important to first explore its history 
as a disorder. The body of work contributing to the medical and psychiatric understanding of 
autism is vast and fragmented. The events selected for this history were chosen based on a 
review of texts which identified sentinel milestones and trends in autism research that has helped 
establish diagnostic criteria, prevalence rates, and explore potential causes and risk factors.  
 Early Autism Accounts 
Many scientists have argued that accounts of autistic-like behaviors can be found 
throughout history in literature and legends, long before psychiatrists and researchers such as 
Leo Kanner and Hans Asperger recorded their observations in the early twentieth century (Wing, 
1997). Folktales of fairies replacing human babies with changeling children, who have voracious 
appetites or the inability to speak, could actually be diagnosed as autistic with the current 
criteria, some scientists insist. Legends about the followers of St. Francis of Assisi around the 
thirteenth century mention a story of Brother Juniper, who lacked social awareness and sense and 
would now likely be diagnosed with Asperger’s syndrome (currently on the spectrum of autistic 
disorders). Prominent psychiatrist Sula Wolff  (2004) wrote in her article on the history of autism 
about “wolf children,” or children discovered in the wild during the 1800s who were found to be 
mute, insensitive to cold, and walked on all fours. There is much speculation, she says, that these 
cases were perhaps some of the first records of children who had what would now be considered 
autism. One of the most celebrated “wolf children” was Victor, described by young French 
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physician Jean Itard as the “wild boy of Aveyron.” Victor was discovered naked and covered 
with scars in the woods of Aveyron, France around the age of 11 or 12. He initially presented 
with an expressionless gaze, melancholy, sensitivity to loud noises, lack of imitation of others, 
gluttony, and made only guttural sounds. Itard attempted to educate and “humanize” him over a 
period of several years and made some progress. Psychiatrists J.K. and Lorna Wing say that 
while Victor was deemed an “idiot” who had been abandoned by his family for that reason, he 
showed most of the diagnostic features of autism (Wing & Wing, 1966).  
These myths and early accounts are discussed in much of the literature about autism and 
are important to mention because they demonstrate that the autistic tendency existed throughout 
history. Today’s scientists use these accounts to explain that autistic behaviors have always 
existed, but those who exhibited them were labeled as insane, “idiots” and/or as mythological 
creatures. These accounts, factual and fictitious, also demonstrate that individuals exhibiting 
what we would now describe as autism-like behaviors seem to have exerted a fascination worth 
noting for the public throughout history (Wing, 2005). Despite these early accounts, the 
connection between them, as well as other stories that attempted to explain weird or strange 
behaviors in children, were not made until the late nineteenth century when British psychiatrist 
Henry Maudsley posited that children who exhibited such behaviors could be afflicted with what 
he called childhood psychosis. In the first half of the twentieth century researchers in the field of 
abnormal child development began defining subgroups within childhood psychoses. It was 
through this work that one might say that autism was discovered. The following section 
discusses the work of those researchers who observed and described these behavior patterns and 
labeled them autism. 
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Labeling and Describing Autism 
Prominent Swiss psychiatrist Eugen Bleuler, who studied schizophrenia, first introduced 
the term “autism” in 1911. According to Bleuler, autism (from the Greek word autos or ‘self’) 
describes how a person detaches from outer reality and immerses in an inner life. Influenced by 
Freud’s notion of autoeroticism, Bleuler believed that autism was used as a defense mechanism 
to avoid the conflicts between desires and reality that occur with schizophrenia. According to 
Bleuler, autism is a fundamental but secondary symptom of schizophrenia (Parnas & Bovet, 
1991). His description of autism included a variety of clinical manifestations: social withdrawal, 
emotional indifference, inappropriate behaviors, and idiosyncratic beliefs and values 
(Stanghellini, 2001). Bleuler’s work led to years of research about autism and its relation to 
schizophrenia, but it is often ignored in the context of the current autism definition because of 
that focus.  
While work continued on autism and schizophrenia, it was Austrian Leo Kanner’s 
adoption and redefinition of the term “autism” that led to its classification as a distinct disorder 
that most closely resembles today’s definition of autism. Kanner’s 1943 article “Autistic 
Disturbances of Affective Contact” first published in Nervous Child is described as one of the 
few scientific papers that has stood the test of time and has received an honored place in the 
history of psychiatry (Rutter, 1985). The article presented case studies of 11 children (eight boys 
and three girls) under the age of 11, most of whom he had carefully observed since 1938 while 
working at Johns Hopkins University. Setting the tone for the cases, he says “there have come to 
our attention a number of children whose condition differs so markedly and uniquely from 
anything reported so far, that each case merits—and, I hope, will eventually receive—a detailed 
consideration of its fascinating peculiarities” (Kanner, 1943/1985, p. 11). Following the riveting, 
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detailed accounts of each child’s case, he notes the emergence of essential common 
characteristics among all of the children that form a unique syndrome, and who previously would 
have been diagnosed as schizophrenic or been labeled feebleminded. He stressed that 
fundamental to this disorder is the children’s inability to relate to themselves from the beginning 
of life, distinguishing it from childhood schizophrenia, which he argued begins after a period of 
average development. Parental accounts of their children as having always been “like a shell,” 
“acting as if people weren’t there,” and “acting almost as if hypnotized” gave rise to Kanner’s 
thoughts that this syndrome was unlike schizophrenia in children or adults. He stated that this 
syndrome is different because “it is not a ‘withdrawal’ from formerly existing participation. 
There is from the start an extreme autistic aloneness that, whenever possible, disregards, ignores, 
shuts out anything that comes to the child from the outside” (Kanner, 1943/1985, p. 41). In 
addition to the extreme autistic aloneness, Kanner listed as the universal characteristics the 
inability to use language for communication, excellent memory, literalness, delayed echolalia 
(described as parrot-like repetitions of heard word combinations that the child stores and utters at 
a later time), and monotonous, repetitive motions and behavior. He concluded that these 11 
children “have come into the world with innate inability to form the usual, biologically provided 
affective contact with people, just as other children come into the world with innate physical or 
intellectual handicaps….For here, we seem to have pure-culture examples of inborn autistic 
disturbances of affective contact” (p. 50).  
In addition to supposing that autism has a biological origin, Kanner’s first publication 
about autism also introduced a controversial hypothesis for a social environmental cause of 
autism that supposes cold, emotionless parents are the cause of autism. He noted among the 11 
children:  
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…there are very few really warmhearted fathers and mothers….Even some of the 
happiest marriages are rather cold and formal affairs. Three of the marriages were dismal 
failures. The question arises whether or to what extent this factor has contributed to the 
condition of the children. The children’s aloneness from the beginning of life makes it 
difficult to attribute the whole picture exclusively to the type of the early parent relations 
with our patients (Kanner, 1943/1985, p. 50). 
This hypothesis was discussed further in a 1949 publication in which Kanner coined the term 
“refrigerator mother.” In his memoir, Leon Eisenberg (2001), who trained with Kanner, stated 
that the concept of an inborn disturbance was not welcome within the field. “The rediscovery of 
the impact of severe maternal deprivation on child development brought psychogenesis to the 
fore. When Kanner coined the term ‘refrigerator mother,’ his view of autism became more 
fashionable; the presumption was that the refrigerator mother produced a frozen child” (p. 745). 
This hypothesis also received significant and lasting attention among the public thanks to the 
work of Bruno Bettelheim, a psychoanalyst who published multiple articles in popular 
magazines as well as his book The Empty Fortress: Infantile Autism and the Birth of Self. He 
suggested that autism develops as a response to extreme negative feelings shown by the parent 
and likened the response to that of inmates of concentration camps (Rutter, 1968/1985). The 
“refrigerator mother” hypothesis has since been discredited and it is now the belief that what was 
observed as unusual features in parents of children with autism were due to shared genes (Wolff, 
2004).  
After his initial publication in 1943, Kanner received much recognition and praise. His 
name has become synonymous with autism and in addition to his coining the term “early 
infantile autism,” the disorder was also referred to as “Kanner’s autism” or “Kanner’s 
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syndrome.” Researchers credit his superb skill at observing and recording behavior for the reason 
that his original description has withstood the test of time and scientific review (Donnellan, 
1985). It should be noted that around the same time of Kanner’s article, Austrian pediatrician, 
Hans Asperger described four cases of what he called “autistic psychopathy.” He noted that 
some of these children had extraordinary gifts in math and science, but lacked the ability to form 
proper social and emotional relationships. Asperger’s complementary work to Kanner’s did not 
get the same recognition until 1981, when Lorna Wing published her seminal paper about the 
pattern of behavior that had been described by Asperger. She called it Asperger’s syndrome, 
which is often referred to as high functioning autism. Many believe that Asperger did not receive 
the same recognition because his work was published in German and not readily available to the 
English-speaking world (Wing, 2005).  
While researchers have regarded Kanner’s original description and terminology over time 
as accurate and clear, the body of “autism” research at the time of its publication lacked unifying 
principles. Edward Ornitz (1973), who reviewed childhood autism in clinical and experimental 
literature, points out that at least six major diagnostic rubrics were used to describe individuals 
(specifically young children) with the set of symptoms that we now call autism. Adding to the 
confusion was Kanner’s decision to use the term “autism” because of its previous association 
with schizophrenia. Kanner admits that the decision to use the term “autism” was done so 
reluctantly. The following is a lengthy citation, but one of great importance, because it explains 
why and how he chose to use the term autism:  
All this does not seem to fit in with Bleuler’s criteria for autism. There is not withdrawal 
in the accepted sense of this word and a specific kind of contact with the external world is 
a cardinal feature of the illness. Nevertheless, in full recognition of all this, I was unable 
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to find a concise expression that would be equally or more suitably applicable. After all, 
these children do start out in a state that resembles the end result of later-life withdrawal 
and there is a remoteness at least from the human portion of the external world. An 
identifying designation appeared to me to be definitely desirable because, as later events 
proved, there was danger of having this distinct syndrome lumped together with a variety 
of general categories (Kanner’s unpublished autobiography, as cited by Donnellan, 1985, 
p. 2).  
Kanner’s use of the term “autism” was indeed confused with Bleuler’s concept of autism as well 
as others who associated autism with schizophrenia (Ornitz, 1973). In fact, much of the work that 
followed Kanner’s original publication focused on establishing criteria for separating the 
diagnosis of autism from a host of other labels for mental impairments (Donnellan, 1985). It was 
not until 1980 that autism was included as a separate diagnostic condition from childhood 
schizophrenia in the third version of the American Psychiatric Association’s (APA) Diagnostic 
and Statistical Manual of Mental Disorders (DSM-III), the standard by which mental disorders 
are diagnosed in the U.S.  
Autism: A Distinct Disorder 
 The journey of the classification of autism as a distinct disorder in the DSM illustrates the 
widespread conflicts, not only in autism research, but in the field of psychiatry as well, which 
struggled to be recognized as a legitimate discipline within the greater medical discipline. The 
publication of DSM-III in 1980 has been called the most important psychiatric publication to 
appear between 1970 and 1980 and has been declared to be the most significant factor in 
promoting the “remedicalization” of American psychiatry (Wilson, 1993). The 
“remedicalization” of American psychiatry refers to the shift from a biopsychosocial model 
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informed by psychoanalysis, sociological thinking and biological knowledge to a research-based 
medical model, often called a biomedical model. Psychiatrist Arnold Ludwig summarized the 
general reputation of psychiatry in the 1970s in his essay for the Journal of American Medical 
Association: “Psychiatry has become a hodgepodge of unscientific opinions, assorted 
philosophies, and ‘schools of thought,’ mixed metaphors, role diffusion, propaganda, and 
politicking for ‘mental health’ and other esoteric goals” (p. 603). For autism and its progression 
in psychiatry, this was the case as well. Kanner reflected in his unpublished memoirs that autism 
had become quite “fashionable” amidst the confusion in the field:  
[I]t became a habit to dilute the original concept of infantile autism by diagnosing it in 
many disparate conditions which show one or another isolated symptom found as a part 
feature of the overall syndrome. Almost overnight, the country seemed to be populated 
by a multitude of autistic children, and somehow this trend became noticeable overseas as 
well. Mentally defective children who displayed bizarre behavior were promptly labeled 
autistic…. (Donnellan, 1985, p. 3).  
Kanner’s reflections illustrate the notion that in the 1950s and 1960s, schizophrenia diagnoses 
were quite common, and in children, that included autism (Wolff, 2004). These diagnoses 
continued throughout the 1960s and 1970s because psychiatrists, pediatricians, and general 
practitioners lacked a unifying language and set of criteria for diagnosis (Rutter, 2005). In 1980, 
with the help of many biomedical autism experts, the APA added autism to the DSM-III as a 
separate condition from childhood schizophrenia and included six mandatory criteria for 
diagnosis. The APA included infantile autism as a part of a class of disorders called Pervasive 
Development Disorders (PDD). The six mandatory criteria for diagnosing infantile autism were 
listed as follows: 
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1. Onset before 30 months of age; 
2. Pervasive lack of responsiveness to other people; 
3. Gross deficits in communication skill; 
4. Peculiar speech patterns, if speech is present; 
5. Bizarre responses to aspects of the environment; and, 
6. Absence of delusions, hallucinations, loosening of associations, and incoherence. 
(APA, 1980, p. 89). 
Despite the monumental accomplishment of establishing these criteria for autism, many felt that 
the descriptor infantile and emphasis on the condition in very young children was problematic 
because it is a lifelong condition.  
Major revisions were undertaken in the DSM-IIIR, published in 1987, to address these 
issues. The APA changed “infantile autism” to “autistic disorder” to reflect that it is a lifelong 
condition. In the DSM-IIIR, the criteria also were expanded to a very detailed list of sixteen 
(eight of which were required for a diagnosis) to encompass developmental changes that can 
occur across the lifespan. Age at onset was also dropped as a diagnostic feature. Another 
category within PDD, called Pervasive Development Disorder-Not Otherwise Specified (PDD-
NOS), was added. According to the criteria, PDD-NOS was a diagnosis used when some 
impairments were observed in social interaction and of verbal and nonverbal communication 
skills, but the criteria were not met for Autistic Disorder, Schizophrenia, or Schizotypal or 
Schizoid Personality Disorder (APA, 1987). Child psychiatrist and primary investigator for APA 
autism research projects Fred Volkmar argued that while the DSM-IIIR was an improvement, 
various studies showed a high rate of false positive cases (Volkmar et al., 1994). He also pointed 
out that the World Health Organization’s International Statistical Classification of Diseases and 
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Related Health Problems-10 (ICD-10) published in 1992 differed from the DSM-IIIR in what 
was included in the pervasive developmental disorders class. The ICD-10 included Rett 
syndrome, Childhood Disintegrative Disorder, and Asperger syndrome within PDD. Volkmar 
ultimately spearheaded the efforts to conduct a large field trial to better understand the reliability 
and validity of the criteria in the ICD-10, DSM-III and DSM-IIIR that would address these issues 
for the next version of the DSM. 
 Volkmar et al. (1994) concluded that the DSM-IIIR criteria were associated with more 
false positive diagnoses and that the ICD-10 criteria proved the best overall for autism. They 
recommended that the DSM-IV use the ICD-10 entry for PDD. Published in 1994, the DSM-IV 
expanded its definition and conditions within PDD to reflect that of the ICD-10:  
Pervasive Developmental Disorders are characterized by severe and pervasive 
impairment in several areas of development: reciprocal social interaction skills, 
communication skills, or the presence of stereotyped behavior, interests, and activities. 
The qualitative impairments that define these conditions are distinctly deviant relative to 
the individual's developmental level or mental age. This section contains Autistic 
Disorder, Rett's Disorder, Childhood Disintegrative Disorder, Asperger's Disorder, and 
Pervasive Developmental Disorder Not Otherwise Specified. These disorders are usually 
evident in the first years of life and are often associated with some degree of Mental 
Retardation…. (APA, 1994, pp. 70-71).  
The DSM-IV also reflected Lorna Wing’s (1981) idea that autism is actually a spectrum of 
disorders (Autistic Disorder, Rett’s Disorder, PDD-NOS, Asperger syndrome, etc.) that are 
related, but vary in severity. Diagnosis depends on which and how many sub-criteria within each 
of the three major impairments the person has. A person will be diagnosed with autism if he/she 
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meets at least eight of the DSM-IV’s sub-criteria. A person will be diagnosed with Asperger 
syndrome if he/she only meets five or six different sub-criteria (APA. 1994). The next revision 
of the manual, the DSM-V, is scheduled for publication in 2012.  
The implications of the classification of autism as a distinct disorder are still being 
debated. From Kanner’s strict criteria for infantile autism, reflected in autism’s first appearance 
in the DSM in 1980, to the current DSM-IV definitions, which present autism as a spectrum of 
disorders that include Asperger syndrome and other developmental disorders, the way autism is 
diagnosed has certainly changed. Having consistent criteria for diagnosis has enabled scientists 
to gather better samples of people with autism to conduct surveillance in terms of prevalence as 
well as research in terms of causes and risk factors. The next two sections will explore how 
changes in the ways that prevalence has been determined is related to arguments about the causes 
of autism and will provide a better understanding for the landscape in which the media have 
framed autism.  
Autism Prevalence and Rates  
Given the changing definitions and criteria for diagnosing autism or autism spectrum 
disorder (ASD) as discussed in the previous section, determining its (or their) prevalence has 
proven to be equally as challenging. Prevalence is the number of cases of a disease or condition 
among a defined group of people during a specific time period and provides an estimate of the 
probability that an individual will have the disease or condition at a point in time (Hennekens & 
Buring, 1987). Prevalence measures are useful for health providers, educators, and policy makers 
so that the public health impact of a specific disease within a community can be assessed to plan 
services (for example, education and therapies) for those living with the condition. Also, 
monitoring a condition in the same way over time allows scientists and researchers to find out 
whether the prevalence of a disease or condition is increasing, decreasing, or staying the same 
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(CDC, 2009b). Monitoring or determining prevalence over time to determine if autism or ASDs 
have been increasing, decreasing or staying the same has proven to be difficult.  
The first attempt to determine prevalence of autism and autistic-like conditions in a large 
population of children living in a defined geographical area began in the mid-1960s with Victor 
Lotter’s study of eight-to ten-year olds in Middlesex County, England (Wing, 1993). It is 
important to review this first attempt because it illustrates how the lack of unifying criteria for 
diagnosing autism has shaped prevalence data and continued to shape prevalence data, which has 
implications for services and, perhaps, awareness of autism for the public and affected families. 
Despite the lack of unifying criteria for diagnoses, Lotter felt that determining prevalence would 
“produce data which indicate fruitful directions for further research, as well as providing useful 
administrative information and permitting the examination of clinical hypothesis,” (Lotter, 
1966/1985, p. 107). Lotter based his case definitions on criteria mainly developed by Kanner. 
Children were screened using a 22-item behavioral questionnaire that was sent to schools and 
other agencies who dealt with children in the area. The questionnaire covered speech, 
movements, social behavior, and repetitive-ritualistic behavior. To increase the thoroughness of 
his case-findings, he also screened medical, psychological, and educational records of 
“handicapped” children as defined by the Education Act of 1944, which included children who 
were blind, partially sighted, deaf, partially deaf, “educationally subnormal,” epileptic, 
physically handicapped, or had speech problems. Within his prevalence rates, Lotter 
differentiated between the 2.0 per 10,000 that exhibited Kanner’s core criteria and the 2.5 per 
10,000 with a less consistent pattern of the criteria. Further, he gave a prevalence of 2.8 per 
10,000 for those he called “non-autistic” but who exhibited some autistic features. Researchers 
argue that if these data were analyzed using current ASD criteria, the overall autism prevalence 
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rate for Lotter’s study would be 7.3 per 10,000 as compared to the 4.5 per 10,000 Lotter reported 
(Rutter, 2005). This study exemplifies the problems of not having established consistent 
diagnostic criteria for decades of autism research. Similar problems arose as others attempted to 
determine prevalence in other populations.  
In 1993, Lorna Wing reviewed sixteen studies of the prevalence of autism in defined 
populations in Europe, the U.S., and Japan and found prevalence rates varied from 3.3 to 16.0 
per 10,000. She speculated that differences may have been the result of variations in 
interpretations of the diagnostic criteria, “even if real variations exist” (Wing, 1993, p. 71). In 
fact, for many years, little was known about the prevalence of ASD in the U.S. because only four 
U.S. population-based studies of autism had been conducted in the 1980s and 1990s (Yeargin-
Allsopp et al., 2003). Three of these studies (North Dakota, Utah, and Northern Arkansas) found 
very low prevalence rates (for example, 4 per 10,000 children). In 1998, the fourth study of 
prevalence took place in Brick Township, New Jersey, and reported a higher rate than any 
previous U.S. study. They found that 40 per 10,000 three- to ten-year-old children had autistic 
disorder. In 1999, Canadian psychiatrist and epidemiologist Eric Fombonne reviewed 23 studies 
from around the world that were published between 1966 and 1998. His research suggested that 
the rate for all pervasive developmental disorders was somewhere between 30 and 60 per 10,000 
(Fombonne, 1999). From these data, advocacy groups and researchers began using the figure one 
in 166 as a generalizable number of people with autism, but the data were not U.S. specific. 
Many believed that these data were evidence that there is an epidemic of autism (Fombonne, 
2001). An epidemic is the “occurrence of a disease in members of a defined population clearly in 
excess of the number of cases usually or normally found in that population” (Friedman, 1980, p. 
73). Further claims about the epidemic of autism were based on a report from California’s 
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Department of Developmental Services (1999) that found between 1987 and 1998, the 
population of people with autism increased from 4.85 to 9.37 percent. Fombonne examined the 
methodology used by the California Department of Developmental services and found several 
problems, including a lack of consideration for changes in diagnostic criteria over time 
(Fombonne, 2001). To collect data for a more accurate prevalence of autism in the U.S., the 
Children’s Health Act of 2000 authorized the Centers for Disease Control and Prevention (CDC) 
to create the Autism and Developmental Disabilities Monitoring (ADDM) Network. 
According to CDC, the ADDM Network is the largest multisite collaboration to monitor 
ASDs in the U.S. with the following goals:  
· obtain as complete a count as possible of the number of children with ASDs in each 
project area;  
· report comparable, population-based ASD prevalence estimates from different sites 
and to determine if these rates are changing over time;  
· study whether autism is more common among some groups of children than among 
others; and,  
· provide data to characterize those among the ASD population. (CDC, 2009b, p. 8)  
Michael Rutter, who has been called the father of British child psychiatry (Pearce, 2005), argued 
that the difference in all prevalence data reported thus far, including those from around the 
world, “clearly demands an explanation” (Rutter, 2005, p. 2). In 2005, he set forth five criteria 
for determining valid estimates of the incidence or prevalence of ASD:   
1. A base population of sufficient size to provide a substantial number of individuals with 
an ASD (so that the confidence interval will be narrow);  
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2. A defined epidemiological population that covers all the individuals likely to be at risk 
for an ASD;  
3. Systematic standardized screening of the total population;  
4. A focus on an age group for which it is known that diagnostic assessments are reliable 
and valid; and,  
5. Diagnosis by trained professionals using high-quality standardized research assessments. 
(Rutter, 2005, pp. 2-3).  
Using Rutter’s criteria to guide its attempt to determine accurate ASD prevalence in the U.S., the 
CDC and its ADDM Network published its first report in 2007 that estimated approximately one 
in 150 eight-year old children living in 14 communities had an ASD in the year 2002.  
In their press release for the report in 2007, the CDC stated that the data were consistent 
with the upper end of prevalence estimates from previously published studies (meaning the one 
in 166 data), and that some of the communities had an estimate higher than those previously 
reported (CDC, 2007a). However, CDC director Julie Gerberding stated that CDC was unable to 
determine if there was a true increase in ASDs. CDC funded 14 states to collect prevalence data 
through ADDM Network and said that these sites did not make up a nationally representative 
sample. They cautioned against generalizing rates to every community in the U.S., but stated that 
the study was designed to provide more consistent and reliable estimates (CDC, 2007b). Case 
determination was completed in two phases: case ascertainment and clinician review. ADDM 
investigators screened records at multiple sources that educated, diagnosed, treated, and provided 
services for children with developmental disabilities and then a panel of clinicians with expertise 
in identifying and assessing ASDs reviewed the abstracted information. They used the DSM-IV-
TR definition of autism to determine whether the identified children met the requirements of the 
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monitoring program and had an ASD (CDC, 2009). The U.S., for the first time, had prevalence 
data from multiple sites that used the same methodologies and criteria for ASDs. Establishing 
that one in every 150 children has an ASD using consistent methodology and criteria seemed to 
be an important milestone in the history of the understanding of autism. In the report, CDC 
interpreted and framed the data as an indication that ASD prevalence “is a continuing urgent 
public health concern” (CDC, 2007b, n.p.). That CDC framed the data as an urgent public health 
concern would seem to have implications for policy makers and healthcare providers, in terms of 
funding and providing services for the thousands of children with ASD. It would also stand to 
reason that it would have implications for the public, especially parents of young children, if it is 
communicated to them as a real health threat or as an epidemic.  
In October of 2009, a report from a study funded by the Health Resources and Services 
Administration (HRSA) showed an autism prevalence of 110 per 10,000 children aged 3- to 17-
years in 2007 (Kogan et al., 2009). That’s roughly one in 90 children. However, the prevalence 
was based on parental reports via a telephone survey. The study’s authors noted several 
limitations including lack of clinical validation. Again, interpretation of these data and of the 
report seems to vary among advocacy groups and the media, but no formal analysis of either has 
been conducted to date. The HRSA report was followed by the second report from CDC and its 
ADDM Network, using the same methodology as its 2007 study, and stated that in 2006, 
approximately 1% or one in every 110 children living in 11 communities had an ASD. The 
report stated the following in regards to whether an increase could be determined from the 2007 
to the 2009 reports:   
The average prevalence of ASDs identified among children aged 8 years increased 57% 
in 10 sites from the 2002 to the 2006 ADDM surveillance year. Although improved 
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ascertainment accounts for some of the prevalence increases documented in the ADDM 
sites, a true increase in the risk for children to develop ASD symptoms cannot be ruled 
out. On average, although delays in identification persisted, ASDs were being diagnosed 
by community professionals at earlier ages in 2006 than in 2002 (CDC, 2009, p.1).  
Despite the clarification on whether a true increase can be determined, as CDC states, there is no 
doubt that more children are being identified and diagnosed with ASD. They stated “These 
results indicate an increased prevalence of identified ASDs among U.S. children aged 8 years 
and underscore the need to regard ASDs as an urgent public health concern” (CDC, 2009, p. 1). 
As with their first report, CDC framed the data as an urgent public health concern. Interpretation 
of these data and of the report which frames the data as an urgent public health concern among 
various sources seems to vary among advocacy groups and the media, but no formal analysis of 
either has been conducted to date. How the public, policy makers, and healthcare providers 
interpret the prevalence data and perceive ASD as a health risk is important to analyze, but the 
first step is to understand how prevalence data are being framed by the media. How the media 
interpret and frame autism prevalence data can influence public perception of autism as well as 
the potential causes of autism. For example, if the media frame autism as an epidemic, it can 
potentially affect government policies and funding for funding autism research and services. Or, 
if the media present information that suggests that autism prevalence has increased over the same 
years that the number of required vaccinations have increased, then the argument for a 
vaccination-autism connection is strengthened, despite the lack of scientific evidence to support 
that claim. The next section explores the research that has been conducted about potential causes 
and risk factors.  
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Autism Causes of and Risk Factors  
There has been research into the causes of autism, yet, it seems there is more controversy 
than conclusion (Donnellan, 1985). One of the most controversial hypotheses early in the history 
of autism research was around the cause of autism was the “refrigerator mother.” As mentioned 
in a previous section, Kanner supposed that autism had a biological origin, but he also posited in 
his 1943 article that cold, emotionless parents could cause autism. Fombonne (2003) points out 
that Kanner’s observations could have indicated that there is a genetic cause, but the 
predominance of psychoanalytical theories and the concentration on maternal deprivation in 
post-World War II child psychiatry led to the “refrigerator mother” hypothesis that was 
perpetuated by Bettelheim. In 1964, research psychologist and father of a son with autism, 
Bernard Rimland, directly attacked the hypothesis with his book Infantile Autism. This sentinel 
publication laid the theory to rest “so persuasively that no serious behavioral scientist has raised 
it again” (Donnellan, 1985, p. 5). Point for point, he reviewed the arguments for the psychogenic 
or emotional causes of autism and contended that the hypothesis lacked evidence-based scientific 
rigor: “We are not saying that psychogenesis is an imaginary influence, we are merely saying 
that there appears to be no evidence that it is anything but imaginary” (Rimland, 1964/1985, pp. 
91-92). He pointed to the numerous cases of attentive parents who had children with autism and 
the non-attentive parents who did not have children with autism. He also made the case for 
biological causation noting that “there are a number of points of information which support the 
hypothesis that autism may result from a rare recessive trait, or be otherwise determined by 
biological factors” (Rimland, 1964/1985, p. 92). Among the nine points were two that suggested 
a genetic component: high sex ratio (three or four boys for every girl) and twins with autism. His 
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arguments have held the test of time and are regarded as the foundation for biological research in 
autism (Holmes, 1985).  
The research that has been conducted to determine the causes of and risk factors for 
autism beyond emotional factors is vast and this review will try to cover them as succinctly as 
possible. That it appears autism prevalence has been increasing (whether it is a true increase or 
due to better diagnoses) has generated many hypotheses about the causes. Scientists are clearly 
not certain about what causes ASD, but it is likely that both genetics and environment play a role 
(National Institutes of Health, 2009). Regarding genes, twin studies, sibling studies, and other 
family studies establish that a genetic susceptibility exists (Newschaffer et al., 2007). Research is 
underway to identify specific autism risk genes; to date more than 100 genes have been studied 
for their association with ASDs. According to an autism fact sheet from the National Institutes of 
Health (NIH) (2009), studies of people with ASD have found irregularities in certain regions of 
the brain and other studies suggest that people with ASD have abnormal levels of serotonin or 
other neurotransmitters in the brain. All of this suggests that ASD “could result from the 
disruption of normal brain development early in fetal development caused by defects in genes 
that control brain growth and that regulate how brain cells communicate with each other, 
possibly due to the influence of environmental factors on gene function” (NIH, 2009, n.p.). 
Prenatal exposure to viruses such as cytomegalovirus and rubella have been linked to autism, but 
most scientists agree that viral exposure is unlikely to account for all of the cases of autism 
(Newschaffer et al., 2007). Three medications have been identified as potential autism risk 
factors when given during pregnancy: thalidomide, prescribed in the 1950s and 1960s for 
morning sickness and anxiety; valproic acid, an anti-epileptic drug that is also used for bipolar 
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disorder and schizophrenia; and, misoprostol, which is used for labor-induced abortion and 
related to ASD among survivors of the procedure (Newschaffer et al., 2007).  
 Some of the most controversial hypotheses about causes have concentrated on 
demonstrating a link between vaccines and autism. As previously mentioned, Wakefield et al. 
(1998) reported in The Lancet that the parents of 8 of 12 children with ASD and bowel 
symptoms who were examined had the onset of behavioral symptoms within a mean interval of 
6.3 days after receiving an MMR vaccine. Although the study never claimed to have definitively 
proven a link between the MMR vaccine and autism, Wakefield’s interviews with the media 
sensationalized the study and seemed to ignite a public panic in Britain. The media coverage of 
this story and its effects will be discussed further in Chapter 2. Following the study’s release and 
media hype, concerns about the study emerged. The reliability and validity of the study was 
criticized because “there were no controls and no case validation” (Taylor, 2006, p. 515). Despite 
the criticism, some parents and researchers remained concerned about the possible link. In the 
U.S., the CDC and NIH engaged the Institute of Medicine (IOM) to examine the hypothesized 
MMR-autism link and address other vaccine-safety issues “in order to give some guidance to 
themselves, health care providers, researchers, and a concerned public” (IOM, 2001, p. 1). In 
2001, the IOM concluded that “The evidence favors rejection of a causal relationship at the 
population level between MMR vaccine and autistic spectrum disorders….A consistent body of 
epidemiological evidence shows no association at a population level between MMR and ASD” 
(IOM, 2001, p. 2). In 2004, 10 of Wakefield's 13 co-authors disavowed the findings of the 1998 
study. In February of 2010, The Lancet retracted the story following the finding of the British 
General Medical Council that said Wakefield and two colleagues acted dishonestly and 
irresponsibly in conducting their research (DeNoon, 2010).  
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 The second controversial vaccine-autism link hypothesis centers around thimerosal, the 
mercury-based preservative that was used in some vaccines. In 1997, Congressman Frank 
Pallone attached an amendment to a U.S. Food and Drug Administration (FDA) reauthorization 
bill which gave the FDA two years to compile a list of drugs and foods that contained 
intentionally introduced mercury compounds (Offit, 2008b). The FDA asked for food and drug 
makers to list the amount of mercury in their products. The analysis of the compiled data found 
that by six months of age, infants could receive as much as 75 micrograms of mercury from the 
preservative thimerosal used in various vaccines. Environmental mercury or methylmercury has 
been shown to cause serious damage to the nervous system and the Environmental Protection 
Agency (EPA) has safety guidelines for it (Offit, 2008b). However, thimerosal contains 
ethylmercury. Unlike methylmercury, ethylmercury does not accumulate in the body or the brain 
and is metabolized and cleared by the body (Miller & Reynolds, 2009). But, the EPA, the 
Agency for Toxic Substances Disease Registry, and the World Health Organization do not have 
standard safety guidelines for ethylmercury (Offit, 2008b). Having no guidelines, the FDA used 
methylmercury-based standards to recommend that thimerosal be removed from routine infant 
vaccines in the U.S. The CDC and the American Academy of Pediatrics promptly released a 
joint statement on July 9, 1999 stating that while there was no evidence that thimerosal had 
caused any harm, the groups agreed that vaccines containing thimerosal should be removed 
given the concerns raised by EPA’s guidelines (Baker, 2008). The effort to remove thimerosal 
from vaccines was largely complete by the summer of 2001. IOM was asked to review the 
hypothesis that thimerosal-containing vaccines caused autism, adding to their previous charge to 
look at the MMR vaccine link. In 2004, the IOM released their report stating that they had 
reviewed the published and unpublished epidemiological studies regarding of potential biologic 
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mechanisms by which immunizations might cause autism. The committee concluded that “the 
body of epidemiological evidence favors rejection of a causal relationship between the MMR 
vaccine and autism. The committee also concludes that the body of epidemiological evidence 
favors rejection of a causal relationship between thimerosal-containing vaccines and autism. The 
committee further finds that potential biological mechanisms for vaccine-induced autism that 
have been generated to date are theoretical only” (IOM, 2004, p.1). Despite the IOM’s reports 
and the lack of scientific literature demonstrating a link between autism and vaccines, the 
controversy seems to persist especially among some communities of parents of children with 
autism and organizations promoting cures for autism (Baker, 2008).  
Currently, organizations such as Generation Rescue (2010, n.p.), which is led by 
entertainer Jenny McCarthy, question the number and contents of vaccines given to children:  
Parents should know that vaccines are never tested for their "combination risk", despite 
the fact that children may get as many as 6 vaccines in a single visit to the doctor. And, 
when it comes to vaccines, how can it be possible that one size fits all? What may present 
as no risks for one child may present enormous risks for another… Many vaccines 
contain other toxic substances including ethylene glycol (antifreeze), phenol (a 
disinfectant dye), benzethonium chloride (a disinfectant), formaldehyde (a preservative 
and disinfectant), and aluminum (another known neuro-toxin). 
The number of shots a child may receive by age two has indeed increased from 11 in 1983 to as 
many as 23 (CDC, 2010). Furthermore, a child might receive up to six shots during one visit to 
the doctor. According to CDC,  
The available scientific data show that simultaneous vaccination with multiple vaccines 
has no adverse effect on the normal childhood immune system. A number of studies have 
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been conducted to examine the effects of giving various combinations of vaccines 
simultaneously. These studies have shown that the recommended vaccines are as 
effective in combination as they are individually, and that such combinations carry no 
greater risk for adverse side effects. (CDC, 2010, n.p.).  
Thus, despite the preponderance of scientific data to the contrary, the autism-vaccine debate 
continues. Baker (2008) argued that parents and clinicians “who have framed autism in 
biomedical terms (such as immune or gastrointestinal dysfunction) have been critical agents in 
promoting both the concept of the ‘autism epidemic’ and the primacy of vaccines as its cause” 
(p. 248).  
Framing autism as an epidemic can potentially affect government policies and for 
funding autism research and services. In simple terms, the bigger a problem it is perceived to be, 
the more government funding it generally receives. In December of 2006, President George W. 
Bush signed The Combating Autism Act, which authorized nearly one billion dollars in 
expenditures, over five years beginning in 2007, for autism research, screening, education, and 
early intervention. Framing vaccines as the cause of autism can potentially result in public health 
crises: 1 in 4 parents believe that vaccines cause autism and the number of measles cases 
reported in 2008 were the highest since 1996 due to parents not vaccinating their children. While 
some parents and advocacy groups have framed autism as an epidemic and caused by vaccines, it 
is important to point out that no authoritative government agency such as the CDC or healthcare 
provider organization such as the American Academy of Pediatricians has framed it in those 
terms. Parents, government agencies, healthcare provider organizations, and advocacy groups 
have certainly contributed the public discourse on a variety of autism issues including causes and 
prevalence. Considering the media’s effect on the decline of MMR vaccines in Britain (Lewsi & 
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Speers, 2003) and the recent survey reporting that 1 in 4 U.S. parents believe vaccines cause 
autism, 81% of whom reported that they had heard or read about problems with the MMR 
vaccine (Freed et al., 2010), this investigation seeks to understand the media’s contribution to the 
public discourse on autism-related issues such as causes and prevalence. The next chapter 
focuses on the analysis of mass media coverage of these autism topics thus far and the theoretical 
grounding for that research and this thesis: agenda setting theory and framing theory. 
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 CHAPTER 2 
THEORETICAL FRAMEWORK: AGENDA SETTING AND FRAMING  
 In order to examine the mass media’s contribution to the public discourse on autism-
related issues such as causes and prevalence, it is important to understand the theoretical 
background that explains how mass media can influence public discourse. Agenda-setting theory 
provides a nice framework to understand how through the selection of news stories, news 
directors focus the public’s attention on some issues more than others and influence perceptions 
of what are the most important issues. A related communication concept, framing, will be used to 
explain how the mass media promote a particular definition of an issue through selection, 
emphasis, exclusion, and elaboration. Current research related to mass media coverage of autism 
is also discussed to demonstrate what is currently known about how media frame autism and 
illustrate the gaps in knowledge around this specific topic that this thesis aims to fill.  
Agenda-Setting  
Decades of research on the long-term implications of journalism show that media 
audiences not only learn factual information from exposure to news, but that people also learn 
about the importance of topics in the news based on what topics the media covers. Cohen (1963) 
observed that the news media do not tell people what to think, instead they tell people what to 
think about. The ability to influence the importance or salience of topics on the public agenda is 
called the agenda-setting role of the media (McCombs, 2004). Maxwell McCombs (2004), one of 
the founding fathers of agenda-setting theory, explains that for all news media, the repetition of a 
topic on a daily basis is the most powerful message of all about its importance. Newspapers 
provide cues about the importance or salience of the topics on their daily agenda with their 
decisions on the lead story, the size of a headline, and the length of a story while television news 
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media provide cues by merely mentioning an issue in their broadcast because of the format as 
well as placement in the broadcast and by the amount of time spent on the story. McCombs 
(2004) explains how these salience cues affect the public: “Establishing salience among the 
public, placing an issue or topic on the public agenda so that it becomes the focus of public 
attention and thought – and, possibly, action – is the initial stage in the formation of public 
opinion.” (p. 2). In terms of story length, the typical evening news segment runs, on average, 
between one-and-a-half to two minutes and may be extended for important news items (Watkins, 
2001). Regarding placement, issues or news items perceived as the most important for that day 
are typically the lead story. “Hard” news items are generally presented near the beginning of the 
broadcast. According to Jamieson and Campbell (1997), “hard news is the report of an event that 
happened or that was disclosed within the previous twenty-four hours and treats an issue of 
ongoing concern” (p. 40). “Soft” news items are placed near the end and tend to address more 
human interest stories and may include more humorous or novel stories (Watkins, 2001).  
Most of McCombs’ research, as well as that of others who used agenda-setting theory to 
explain media effects, has focused on the media’s role in emphasizing political issues and 
subsequent voter behavior and political attitudes. But within the last 20 years, more agenda-
setting researchers have been examining other issues, such as health-related behaviors and 
perceptions (Ogata Jones, Denham, & Sprinston, 2006). These include the agenda setting role of 
the media regarding smoking (Sato, 2003), health care reform (Hacker, 1996), AIDS policy 
(Backstrom & Robins, 1998), and breast cancer screening (Ogata Jones et al., 2006).  
  Given that many journal articles are published every month with research findings that 
have the potential to impact the public’s health, and many organizations promote and advocate 
for thousands of health conditions, how do the media decide which journal articles or health 
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issues are newsworthy? This question is of particular interest for this study. In a recent survey of 
health and medical science reporters and editors, Viswanath et al. (2008) found that the initial 
idea for a health-related story most often originates from a news source suggestion. A news 
source is defined as “a person with whom the reporter is frequently in contact with to obtain 
information” (p.769). Reporters also named resources such as press conferences or press releases 
and wire service items as generators of initial ideas. There were differences among reporters 
depending on their reach (national versus local) and medium (broadcast vs. print). National news 
reporters said they most often get their initial idea for a story from scientific journals; local news 
reporters said they rely most on suggestions from a source. Broadcast news journalists reported 
that they rely on a suggestion by a source or wire services more often than print reporters. 
Regarding news sources, national reporters mentioned using scientists and researchers most 
often. Broadcast journalists were significantly more likely to report using scientific journals for 
their initial ideas compared with print reporters. Broadcast journalists said that potential for 
public impact, new information and development, and ability to provide human interest were the 
most important criteria for determining newsworthiness. For the purposes of this research, which 
seeks to investigate television broadcast news, it is important to note that these three criteria were 
rated significantly higher for broadcast journalists than print reporters. This suggests that 
broadcast stories related to autism might differ from print stories, which have been the primary 
focus of previous research on media coverage of autism. Studies of how reporters “decide” what 
is news and how they “construct” news can be helpful in the understanding of the agenda-setting 
role of the media and provides a transition for a discussion in the next section on another 
communication concept: framing.    
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Framing and Second-Level Agenda Setting 
That broadcast journalists determine newsworthiness of a health topic based on its 
potential for public impact, new information and development, and ability to provide human 
interest is not surprising because journalism is grounded in storytelling and is constructed as 
such. Walter Lippmann’s opening chapter of Public Opinion argued that public opinion responds 
not to the environment, but to the pseudoenvironment constructed by the news media (McCombs 
& Reynolds, 2002). He also argued that the news media are a primary source of the pictures in 
our heads (McCombs, 2004). Both of Lippmann’s arguments speak to the process by which the 
media’s stories are told and organized in addition to the media’s role in agenda-setting. Agenda-
setting theory researchers have proposed that media messages contain an agenda of both objects 
and attributes. In the context of politics, objects are equivalent to issues or candidates and 
attributes are properties associated with the objects. For this study, the object or the issue is 
autism and the attributes include the controversy about what causes autism, the vaccine-autism 
hypothesis and the characterization that autism is increasing. McCombs and Ghanem (2003) 
argue that the objects and attributes presented in media vary in salience or importance—that is—
the media present some objects, such as autism, and attributes, such as the controversy related to 
vaccines causing autism as more important for the public than other attributes. Further, 
McCombs and Ghanem suggest that agenda setting has two levels: the first level is the 
transmission of object salience from the mass media’s pictures of the world to those in our heads; 
the second level is the transmission of attribute salience. This second level, attribute agenda 
setting, illustrates that in addition to the media telling us what to think about, they also tell us 
how to think about some objects. McCombs (2003) suggests that this is actually what other 
scholars refer to as framing and that framing is a dimension of agenda-setting.  
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McCombs (2004) defines framing as the central organizing idea for news content that 
supplies a context and suggests what the issue is through the use of selection, emphasis, 
exclusion and elaboration. Other scholars, such as Entman (1993), state that framing occurs 
when the media select certain aspects of a topic and make them more salient in a communicating 
text, in such a way as to promote a particular problem. Both, it seems, have similar definitions 
for framing. However, Entman (1993) adds that frames have at least four locations in the 
communication process: the communicator, the text, the receiver, and the culture. According to 
Maher (2003), framing scholarship concentrates on the communicator’s framing or the 
journalist’s framing of the text and agenda-setting scholarship focuses on the transfer of framing 
salience between the text and the receiver (the public).  
While many scholars have debated the differences, researchers from both traditions are 
recognizing their common ground and see advantages to using both frameworks: agenda-setting 
studies are increasingly measuring the transfer of framing from media to public and framing 
studies are increasingly measuring audience effects (Maher, 2003). For the purposes of this 
study, agenda-setting theory provides the framework for which to examine autism as a topic 
covered by the media. Has coverage increased over time? Is its placement in evening news 
broadcasts prominent? How much time do broadcasts devote to covering autism? Framing 
provides the lens for exploring how the media covers autism and related issues: causes and 
prevalence. According to Entman (1991, p.9), “the essence of framing is sizing—magnifying or 
shrinking elements of the depicted reality to make them more or less salient.”  Further, he says 
that in texts such as evening news broadcasts, frames “are manifested by the presence or absence 
of keywords, stock phrases, stereotyped images, sources of information, and sentences that 
provide thematically reinforcing clusters of facts or judgments” (Entman, 1993, p. 52). Another 
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important concept described in the framing literature that is important for this study is the 
applicability effect. Applicability refers to the audience’s acceptance that two concepts are 
related after exposure to a media message that suggests there is a connection between two 
concepts (Scheufele & Tewksbury, 2007). This effect is especially relevant for this study when 
considering whether the media have framed autism as potentially caused by vaccines and/or as 
an epidemic because of the potential public health implications associated with these frames. 
Before testing for audience effects, however, it is important to know how often the media 
connect autism with both vaccines and epidemics.   
Like agenda-setting, much of the research related to framing has been conducted with 
political media coverage, but it has been used to better understand the role of media portrayals of 
a few health contexts (e.g., health reform, organ donation, breast cancer). Similar to the framing 
of other social issues such as poverty and crime, research on the framing of public health issues 
has shown once a health problem is discussed in the public sphere, responsibility for the health 
problem is a main focus (Lawrence, 2004). The discussion of who or what is responsible for the 
health problem can influence public opinion and policies. Nathanson (1999) adds that public 
health policies are adopted in response to perceived danger and identifies dimensions of how 
public health risks are framed for those purposes:  
In any given case, risks may be portrayed as acquired deliberately or involuntarily (and 
the victims as correspondingly culpable or innocent), as universal (putting us all at risk) 
or as particular (only putting them at risk), as arising from within the individual or from 
the environment, as visible or invisible. The most acceptable risks are universal, are 
attributable to the external environment, and are incurred involuntarily by innocent 
victims. (p. 446).  
35 
This is particularly important when thinking about the framing of autism. If the media frames 
autism as an epidemic, then that would imply that more children could be at risk than previously 
thought—that it is, in a sense, universal (depending on the media’s and the public’s definition of 
an epidemic). If the media portray autism as caused by vaccines or emphasize the connection 
between autism and vaccines, then that would mean that autism is incurred involuntarily by 
innocent victims because many state governments mandate vaccinations: i.e., there is someone or 
something to blame. However, the general consensus among the scientific community around the 
causes of autism is that both genetics and something in the environment play a role (National 
Institutes of Health, 2009). The focus on genetics may not resonate as well with parents because 
it suggests that they (or their genes) play a role—or that the parents are somehow to blame, 
which harkens back to the time of the “refrigerator mother” hypothesis. For the media, it seems 
that the autism-vaccine debate has set up a dramatic storyline ripe with just enough controversy 
worthy of reporting, regardless of the overwhelming scientific evidence that vaccines do not 
cause autism. Explaining the role of genetics may be too difficult for reporters and for the media 
audience because they are complicated scientific topics. Emphasizing the potential role of 
vaccines may be easier because the government requires most children to be vaccinated, which 
affects most parents and would mean that more parents would be engaged by a story of this 
nature. The next section will focus on the current literature related to both how autism has been 
framed by the media and the impact of the mass media coverage of autism on public perceptions 
and behaviors.  
Mass Media Coverage of Autism 
Interest in the analysis of news media coverage related to autism started when scientists 
and others began to see the impact of the previously mentioned Wakefield study in the Lancet. In 
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1998, the Lancet journal article presented findings that demonstrated a potential link between the 
measles virus and autism, suggesting that the vaccine for measles, mumps, and rubella (MMR) 
caused autism. After Wakefield’s study was published in 1998, MMR vaccination rates in 
Britain fell from a high of 92% to below 80% in 2003 (Lewis & Speers, 2003). Attempts to 
explain the fall of vaccination rates point to the media’s coverage of the issue. Lewis and Speers 
(2003) conducted a content analysis of British print, television, and radio news coverage of the 
controversy from January to September 2002. The analysis revealed that 69% of MMR stories 
focused on a link between the MMR vaccine and autism and 58% of MMR stories mentioned 
Wakefield’s proposal for three single vaccines. Despite the large body of scientific evidence that 
disputes Wakefield’s findings, research indicating the safety of MMR was featured in only 37% 
of stories. Lewis and Speers observed that the MMR vaccine became controversial during this 
time period (January through September, 2002) because  a BBC television program Panorama, 
aired a broadcast titled “How safe is MMR” on February 3, 2002, taking up Wakefield’s theory 
regarding the MMR vaccine. Wakefield and other colleagues also pre-published a paper in 
Molecular Pathology that was made available when this broadcast aired. Reporting of a measles 
outbreak in a middle-class London suburb also highlighted the controversy during this period of 
time. Lewis and Speers note that this was not the first time the MMR vaccine had been under 
media scrutiny (i.e., 1998), but that these events threw the vaccine back into the public spotlight 
in 2002. To better understand whether a media agenda-setting effect was in play, Lewis and 
Speers (2003) supplemented their content analysis with two national surveys of British adults. 
Their surveys examined whether the general public was able to recall the dominant themes and 
overall frameworks of autism news coverage. In both surveys, two-thirds of the respondents 
(67%) indicated an awareness of the research showing that the MMR vaccine was unsafe and 
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recalled that autism was the focus of the research. Fewer than one in every four respondents were 
aware that the majority of scientific evidence shows no link between MMR and autism. The 
authors noted that the negative media attention and decline in public confidence in the MMR 
vaccine seemed largely a British phenomenon. This attention to analysis of British media 
coverage and effects related to autism and the MMR vaccine provides a starting point from 
which researchers began to examine media coverage related to autism in the U.S.  
In 2007, one of the few analyses of autism and the media in the U.S. examined autism 
topics covered by the media from 1994 to 2004 and compared them to the autism topics covered 
in the scientific literature and the autism topics that were receiving funding (Singh et al., 2007). 
Brain and behavior research was identified as a main focus of new grants in autism research in 
all samples examined from the U.S., Canada, and Britain (42% of the total grants) and as a main 
focus in the scientific peer-reviewed literature (41% of papers). In stark contrast, brain and 
behavior research accounted for merely 11% of articles about autism research in major 
international print media in those same countries. The study’s authors also noted a paradox in 
coverage of genetics research. Genetics research was identified as the second most frequently 
identified category of new grants in autism research and represented 34% of the focus of the 
scientific peer-reviewed literature. However, genetics research accounted for only 7% of the 
print press articles. The greatest paradox identified by the study was that the media’s intense 
focus on environmental causes and epidemiology research (48% of media articles) far exceeded 
research grants (7%) and scientific peer-reviewed literature (13%). Singh et al. (2007) found that 
this disproportionate reporting correlated with the high coverage of the Wakefield study. Among 
all media articles with an environmental focus, 70% discussed the MMR vaccine and 40% 
referred directly to the Wakefield study. Singh et al. (2007) point out that the media coverage of 
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MMR can be viewed as a “reasonable reflection of the issues deemed most important by the 
public…it could be argued that it is the funding agencies that are out of step: media coverage of 
autism based on the controversy of MMR not only stimulated awareness of autism but also 
highlighted the need for additional research in the causes and treatments of this disorder” (p. 
158).  
At the very least, the Singh et al. (2007) case study demonstrates that priorities of media, 
science, and government can diverge, at least in terms of autism. The authors argue that this in 
turn leaves the scientific community and government agencies at odds with the media in terms of 
the perception of scientific data, which can ultimately influence public perception. The authors 
conclude that their perspective is limited by several factors, including that their study did not 
account for the television coverage of the issue, in which the stories of advocacy groups, 
families, and celebrities are able to be told in a more captivating audio-visual format. Despite its 
limitations, this research contributes to the small growing body of autism-related media coverage 
analysis in that it highlights the importance of examining how media choose what is newsworthy 
as it relates to autism research.  
Clarke (2008) analyzed major national newspaper coverage of the autism-vaccine 
controversy from February 1998 to June 2006 in Britain and the U.S. to better understand how 
the media frames and “balances” the presentation of findings and coverage of the debate. Among 
the most noteworthy of the study’s findings was the coverage pattern of the controversy: 
relatively low coverage from 1998-2000, increased attention from 2001-2002, falling coverage in 
2003, a spike in articles in 2004, and a steady decline in 2005 and 2006. Clarke found the 
increased attention to those studies showing a link between autism and vaccines from 2001-2002 
and 2004 among British newspapers especially troubling because it was a time when the 
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scientific consensus refuting vaccines was strengthened. According to the article, studies/claims 
refuting that vaccines cause autism were significantly more likely to appear in newspapers from 
the U.S. (41%) than in British newspapers (10%). Furthermore, newspapers from the U.S. did 
not devote significant attention to studies/claims that vaccines cause autism by themselves in any 
single year analyzed. In contrast, U.S. newspapers were far more likely to devote significant 
attention to studies/claims refuting that vaccines cause autism by themselves, especially in 2002 
and 2004-2006. 
While the analysis of news media coverage related to autism has provided some insights, 
it does not provide a complete picture of their contribution to the public discourse on the issue. 
Most analyses focus on print media coverage and/or coverage of the MMR vaccine controversy 
in Britain. The MMR vaccine and autism media coverage in Britain and the subsequent decline 
in vaccination rates demonstrate the power of the mass media to contribute to potential public 
health crises. Given that 1 in 4 parents surveyed in the U.S. believe vaccines cause autism (Freed 
et al., 2010) warrants further examination of how the U.S. media have framed the hypothesis 
along with potential causes that have received more scientific confirmation. As demonstrated in 
Chapter 1, there are other issues that have potentially shaped the public’s understanding of 
autism; how the media interpret and frame autism prevalence data can influence public 
perception of autism as well as the potential causes of autism. For example, if the media frame 
autism as an epidemic, it can potentially affect government policies and funding for funding 
autism research and services. 
Research Questions 
      As noted in the literature review, television news media provide cues of an issue’s 
importance by placement in the broadcast and by the amount of time spent on the story. 
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Therefore, the first set of research questions were designed to capture the salience of autism 
related news stories. 
RQ 1a:  Did the frequency of autism-related television evening news stories increase, 
decrease, or remain relatively stable during the study period?  
RQ 1b:  Did the placement of autism-related television evening news stories become     
more prominent, less prominent, or remain relatively the same during the study period?   
RQ 1c: Were there significant differences in the frequency of autism-related stories  
between the networks (ABC, CBS, or NBC) regarding length of story as well as  
placement? 
As noted in the literature review, scientists are not certain about what causes autism, but 
agree that it is likely that both genetics and environment play a role. Some of the most 
controversial hypotheses about causes have concentrated on demonstrating a link between 
vaccines and autism. Therefore, this second set of research questions were designed to 
understand which hypotheses and research about potential causes have received the most 
coverage and how the causes were framed.  
RQ 2a:  How frequently did autism-related television evening news stories mention or     
focus on potential causes during the study period? 
RQ 2b:  What causes were addressed the most frequently?  
RQ 2c:  When an autism-related story included one cause, how frequently were other 
causes also discussed? 
RQ 2d:  How frequently was each cause presented as 1) likely to cause autism, 2) 
unlikely to cause autism, and 3) a potential cause, but with the suggestion that more 
information is needed to determine if it causes autism? 
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RQ 2e: Did the framing of vaccines as a likely cause of autism increase, decrease, or 
remain relatively stable during the study period? 
RQ 2f:  Were there significant differences in the frequency of vaccine-related autism 
stories between the networks (ABC, CBS, or NBC) during the study period? 
RQ 2g:  Were there significant differences in the frequency that the networks (ABC, 
CBS, or NBC) framed vaccines as a likely cause of autism?  
As noted in the literature, how the media interpret and frame autism prevalence data can 
influence public perception of autism as well as the potential causes of autism. For example, if 
the media frame autism as an epidemic, then it can potentially affect government policies and 
funding for funding autism research and services. Therefore, the third set of research questions 
were designed to examine what prevalence numbers, rates, or statistics the media used in 
describing the number of people with autism, when they were used, and how they were framed 
(e.g., as increasing, representing an epidemic or a public health concern).  
RQ 3a: What prevalence/rates of autism were cited each year? 
RQ 3b:  How frequently did television evening news coverage suggest that autism 
prevalence is increasing? 
RQ 3c:  How frequently was autism framed as an “epidemic” in television evening news 
during the study period? 
RQ 3d:  How frequently was autism framed as a “public health concern” in television 
evening news during the study period? 
RQ 3e: Were there significant differences in the frequency that the networks (ABC, 
CBS, or NBC) framed autism as increasing, an “epidemic,” or a “public health concern?”  
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The fourth set of research questions were designed to examine who the media 
interviewed in news stories, and more specifically, who the media interviewed about causes and 
the hypothesis regarding vaccines causing autism. Although journalists sometimes are 
eyewitnesses to events, they tell stories primarily through sources rather than through their own 
observations (Singer & Endreny, 1993). According to Singer and Endreny (1993), journalists 
select individuals to interview for a story based on who has authoritative personal knowledge 
regarding an event and factors such as availability or access and suitability or newsworthiness. 
Journalists ultimately decide which interviews and material from those they have interviewed are 
incorporated into their news report. Examining who the media interviews, specifically about 
cause and the hypothesis regarding vaccines causing autism, can help understand how these 
issues are framed for the public. As noted in the literature review, despite the IOM’s reports and 
the lack of scientific literature demonstrating a link between autism and vaccines, the idea that 
vaccines causes autism seems to persist especially among certain communities of parents of 
children with autism (Baker, 2008). If the media consistently interviews parents who believe that 
vaccines cause autism and medical experts from the government or health professional 
organizations who say vaccines are safe, then this could be viewed as framing the issue as 
parents versus the government or the medical establishment for the public. The audience is left 
having to decide whether they find information from parents or the medical 
establishment/government more believable or credible based on interviews.  
RQ 4a: Who was most frequently interviewed in autism-related stories in television 
evening news during the study period? 
RQ 4b: Who most frequently was interviewed in stories that mentioned or focused on 
potential autism causes of autism in television evening news during the study period? 
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RQ 4c: Who was most frequently interviewed about vaccines in television evening news 
during the study period? 
RQ 4d: Of those interviewed about vaccines, which categories of people were presented 
most frequently as making a case for vaccines as a cause for autism and most frequently 
making a case against vaccines as a cause of autism.  
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CHAPTER 3 
METHODS 
As indicated in the literature review, a recent survey conducted by Pew (2008) showed 
that 29% of respondents reported watching nightly network news. That is up slightly from the 
2006 report showing 28% watched nightly network news. An equal number of respondents 
reported watching either NBC’s Nightly News or ABC’s World News Tonight (14% each) and 
8% reported watching the CBS Evening News. Therefore, this study examined the content of 
television evening news broadcast from the largest networks: ABC, NBC, and CBS. Content 
analysis involves examining texts to understand what they mean to people, what they enable or 
prevent, and what the information presented to them does (Krippendorff, 2004). Content analysis 
of health-related messages has proven to be a useful tool for those researchers within 
communication and health fields especially for research that seeks to draw implications for 
audience effects (Kunkel, 2009). 
Selection of Broadcast Transcripts 
The news reports were selected through a LexisNexis Academic Universe search for the 
words “autism” and “autistic” in the headline of the broadcast transcripts section between 
January 1994, when autism was recognized as a spectrum of disorders in the DSM-IV, to April 
2010, the time of this study. The primary goal of this study was to understand the frequency and 
prominence of autism-related stories throughout the study period and how autism prevalence and 
causes were framed. Only stories that had “autism” or “autistic” in their headline were analyzed 
(N=121). The focus of this study was to examine stories that have the greatest potential to impact 
public opinion about autism, which is more likely to happen when autism is the primary focus of 
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a news piece, and identified as such through a headline, than when autism is briefly mentioned 
within a news story.  
To test accuracy of search results, the data obtained from LexisNexis Academic Universe 
were compared with the search results from the Vanderbilt Television News Archive. This 
archive contains recordings and summaries of U.S. television news broadcasts from 1968 to the 
present time. The Vanderbilt Television News Archive also provides an entire listing of all 
stories appearing during a specific broadcast and the order in which they appear as well as the 
amount of time spent on each story—both of which are important for determining saliency, 
according to McCombs (2004), but neither of which were accessible through the transcripts 
provided by LexisNexis Academic Universe. Thus, both sources were used. Because the 
Vanderbilt Television News Archive provides the most extensive and complete archive of 
television news, it was considered the standard by which additional searches were conducted in 
LexisNexis Academic Universe to find transcripts that did not show up in the initial search. An 
initial search of LexisNexis Academic Universe for “autism” and “autistic” in the headline from 
January 1994 to January 2010 yielded 81 stories. In order to capture stories occurring after 
January 2010 that may have acknowledged the Lancet’s retraction of the initial Wakefield et al. 
study linking autism to vaccines on February 2, 2010, the study period was expanded from 
January 1994 to April 1, 2010. Cross-referencing the stories with the Vanderbilt Television 
News Archive and expanding the study period from January 1994 to April 2010 yielded 121 
autism-related stories. Thus, the use of both sources ensured that more stories focusing on autism 
in television evening news coverage were captured and analyzed.  
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Coding Procedure 
Each news broadcast story served as the unit of analysis for this study and the following 
variables were coded within each autism news story (see Appendix A for the Content Analysis 
Codebook and Appendix B for the Content Analysis Coding Sheet): 
Prominence of autism-related stories. McCombs (2004) argued that television news 
media provide cues about the importance or salience of the topics by the placement in the 
broadcast and by the amount of time spent on the story. This study examined whether the 
placement of autism-related stories has increased, decreased, or stayed the same during the study 
period by coding each story as the lead story, before the first commercial or lead story after the 
first commercial, last story, or other (defined as placement anywhere not included in the other 
choices). This study also examined the length of autism-related stories during the study period by 
coding the duration in 30-second intervals.  
   Causes of and risk factors for autism. Given the controversial nature of the research on 
causes of autism, it is important to understand which hypotheses and research have received the 
most coverage. Stories that included causes were coded as either mentioned in the story (but not 
the main focus) or coded as the main focus of the story. If causes were either mentioned or the 
main focus of the story, then each potential cause or risk factor (below) was coded as not 
included, mentioned, or as the main focus of the story. The following potential causes were 
coded:  
· Genetics or genes—Stories suggesting genes or genetic causes may include the words 
“family history,” genes from mother or father, and/or twins or siblings. These stories 
could also include the identification of “risk” genes or genes that have been identified by 
scientist as increasing the risk for autism.  
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· Brain/Neurological Irregularities—Stories that suggest that irregularities in regions of the 
brain is a cause of autism. This may also include mention of abnormal levels of serotonin 
or other neurotransmitters as a cause of autism. 
· Prenatal Exposure to Viruses—This is defined as prenatal exposure to viruses as a cause 
of autism. Some viruses that may be mentioned such as cytomegalovirus or CMV and 
rubella. 
· Medications—This may include medications such as, but not limited to thalidomide, 
valproic acid, and misoprostol as potential causes of autism.  
· Vaccines—This includes vaccines, such as, but not limited to, the vaccine for Measles, 
Mumps, and Rubella or MMR; thimerosal, a preservative in vaccines; and/or the number 
of vaccines given as a cause of autism.  
· Environment—This may include something in the environment that can cause autism. 
This includes using the word “environmental” or “environment” and/or toxins, chemicals, 
pollutants or pesticides. 
· Other—Other is defined as a cause or potential cause of autism this was not mentioned 
above. The coder was asked to write in the cause if other was circled. 
Then each factor that was coded as mentioned or main focus of the story was coded as 
the “story suggests that the cause or risk factor is unlikely,” “story suggests that the risk factor is 
likely,” or “the story suggests that not enough is known or it is inconclusive as a cause or risk 
factor.”  
Rates or prevalence of autism. Given the struggle to determine accurate criteria for an 
autism diagnosis, which has in turn affected the ability to determine true prevalence, it is 
important to examine how the prevalence data or rates/estimates have been characterized by the 
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media to better understand their contribution to the public discourse on the issue. It is also 
important to examine what prevalence numbers or rates the media uses in describing the number 
of people with autism and when they were used. The following numbers were coded based on 
prevalence rates identified in the literature review: 
· 4.5 per 10,000 (first numbers reported in 1966 in England) (Lotter, 1966/1985) 
· 67 per 10,000 (Brick Township, NJ numbers reported in 1998) (Yeargin-Allsopp et al., 
2003) 
· 60 per 10,000 (Fombonne, 1999) 
· 1 in 166 (Fombonne, 1999) 
· 1 in 150 (CDC, 2007a) 
· 1 in 90 or 1 in 91 (Kogan et al., 2009) 
· 1 in 110 (CDC, 2009) 
· 1% or 1 percent (CDC, 2009) 
· Other 
After coding “Other” stories, the “Other” category was examined and when a figure was 
identified at least 5 times, a new category was created. The estimated rate of 500,000 or 560,000 
children with autism was added and coded because it was identified in stories at least 5 times. 
This rate was previously identified in a CDC press briefing transcript when it released the 1 in 
150 prevalence data. CDC stated that 1 in 150 prevalence corresponded to about 560,000 
children ages 0 to 21 years (CDC, 2007c).  
The stories were then coded as to whether or not they suggested that the rates/estimates 
or prevalence of autism are increasing [no/yes]. In addition, the U.S. government has called 
autism an “urgent public health concern,” while advocacy groups have used the term “epidemic.” 
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The stories were coded to identify the frequency that each of these terms/phrases was included in 
the stories.  
Sources. Because this study is exploratory in nature and seeks to understand how the 
media have contributed to the public discourse on autism, it was important to examine who the 
media interviews in news stories. The following categories of people who were interviewed were 
coded: 
· Government health officials—including doctors, epidemiologists, and scientists 
from state governments as well as national government agencies such as the 
Centers for Disease Control and Prevention (CDC), National Institutes of Health 
(NIH), Environmental Protection Agency (EPA), the U.S. Department of Health 
and Human Services (HHS), or the U.S. Food and Drug Administration (FDA);  
· Medical experts from hospitals, medical experts from advocacy or non-profit 
organizations such as Autism Speaks, Cure Autism Now, or Autism Society of 
America.  
· Parents of or family members of people with autism were coded as well as people 
with autism.  
· Celebrities were included as well given that the influence of celebrities or public 
figures on health knowledge, attitudes, and behaviors has been documented in the 
cases of Katie Couric and colon cancer screening (Cram, Fendrick, Inadomi, 
Cowen, Carpenter, & Vijan, 2003), ‘Magic’ Johnson and HIV prevention 
messages (Flora, Schooler, Mays, & Cochran, 1996), and Nancy Reagan and 
choice of surgery for breast cancer (Nattinger, Hoffmann, Howell-Pelz, & 
Goodwin, 1998).  
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· Health professionals representing health professional organizations (such as the 
American Academy of Pediatrics) were coded.  
· Leaders of advocacy or non-profit organizations such as Autism Speaks, Cure 
Autism Now, Autism Society of America, etc. who were not labeled as having 
medical degrees were coded. Researchers or representatives from universities 
were coded. The category of “other” was provided for those individuals who were 
identified in such a way that did not fit into the given categories.  
· Multiple categories could be coded, if, for example, the person interviewed was 
identified in the transcript as a parent and a celebrity.  
Each person interviewed was coded to identify whether they presented a message 
suggesting there is no link between autism and vaccines (anti-link), presented a message 
suggesting there is a link between autism and vaccines (pro-link), or presented no message 
related to the subject of vaccines. This study used the same methods as Clarke (2008) to code for 
“anti-link” or “pro-link.” “Anti-link” is defined as the person being interviewed indicates that a 
link between autism and vaccines is improbable, unsupported by evidence, or disproved. “Pro-
link” is defined as the person being interviewed indicates that the theory or idea of vaccines 
causing autism is possible, plausible, or probable. “Not sure” was also coded if the person 
presented views that could be coded “pro-link” or “anti-link.” Following the coding of all stories, 
the study author decided to change those items coded as “Not sure” to “pro-link.” The “pro-link” 
definition states that the person indicates the theory of vaccines causing autism is possible. The 
study author recognized that a person who was “not sure” whether vaccines caused autism could 
be categorized as believing the theory is possible since they discussed vaccines and did not rule 
them out as a potential cause.  
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Reliability 
The author and a non-researcher1, who was unfamiliar with the goals of the study, each 
coded a random selection of 10% (N=12) of the transcripts to be coded in the study in order to 
determine intercoder reliability. The non-researcher coder was trained by reviewing the 
codebook (Appendix A) and the coding sheet (Appendix B) with the author/researcher to ensure 
that both understood what they were coding in the stories. Cohen’s kappa was used to assess 
reliability for each variable coded. Kappa values ranged from .769 to 1, with an average of .959, 
indicating excellent agreement (Neuendorf, 2002; Banerjee, Capozzoli, McSweeney & Sinha, 
1999). Table 3.1 provides the kappa values for each variable except for those that had a kappa 
value of 1, indicating perfect agreement. There were a total of 98 variables coded.  
Table 3.1. Intercoder Reliability: Variables and corresponding kappa values (excluding variables 
with kappa value of 1) 
Variable Kappa value 
Placement .882 
Causes: focus of the story .838 
Vaccines (cause) .769 
Rates/Prevalence: focus of the story .867 
Rates “increasing” .871 
“Public Health Concern” .800 
First person interviewed (category) .874 
Second person interviewed (category) .875 
Second person interviewed and their beliefs 
regarding vaccines ( “pro-link” or “anti-link”) 
.888 
Third person interviewed (category) .883 
Third person interviewed and their beliefs 
regarding vaccines (“pro-link” or “anti-link”) 
.891 
Fourth person interviewed (category) .860 
Fifth person interviewed (category) .855 
 
                                                        
1 “non-researcher” is defined as someone who does not conduct quantitative or qualitative research to test 
hypotheses or answer research questions. In this case, the coder was an attorney and had no professional experience 
in conducting research, communication or other types.  
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Data Analysis 
Frequency tables were used to provide descriptors for each variable at the nominal level: 
determining the salience of autism-related stories (placement and length of story), understanding 
which theories and research have received the most coverage regarding the causes of autism and 
how they are framed, understanding which prevalence data and numbers have been used by the 
media to describe the number of people with autism and how these numbers have been framed, 
and understanding who the media interviews the most regarding autism-related stories. Chi-
square analyses were employed to determine if significant differences existed between the 
networks’ coverage in the frequency of autism-related stories, vaccine-related autism stories, and 
the framing of vaccines as a likely cause. A one-way analysis of variance (ANOVA) was used to 
determine if significant differences existed between the networks in terms of length of autism 
stories. The next chapter focuses on the results of this data analysis. 
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CHAPTER 4 
 
RESULTS 
 The sample included 121 transcripts of autism stories appearing in evening television 
news broadcasts between January 1994 to April 2010. Of these, 36.4% appeared on ABC 
(N=44), 32.2% appeared on CBS (N=39), and 31.4% appeared on NBC (N=38). The median 
length of story ranged from 2:01 to 2:30 minutes. More than three-fourths of the autism-related 
stories that were coded had a prominent placement in the newscast: 8.3% were the lead story 
(N=10); 42.1% were before the first commercial or lead story after the first commercial (N=51); 
and, 25.6% were the lead story after any other commercial than the first story (N=31).  
Prominence of Autism-related Stories 
 The first set of research questions were designed to capture the salience of autism related 
news stories. Research question 1a addressed whether the frequency of autism-related television 
evening news stories increased, decreased, or remained stable during the study period. As shown 
in Figure 4.1, the number of autism stories increased from 2001 (N=2) to 2002 (N=12). The 
number of autism stories also increased from 2006 (N=14) to 2007 (N=25), the most of all the 
years in the analysis (20.7%). There was a slight decrease from 2007 (N=25) to 2008 (N=20) as 
well as from 2008 (N=2008) to 2009 (N=17). No stories focusing on autism appeared on any of 
the major television networks evening news broadcasts in 1994, 1995, and 1998. Television 
evening news coverage of autism-related issues increased yearly starting in 2004 until peaking in 
2007. Since 2005, between 12 and 25 autism-related news stories have appeared on television 
evening news programs per year.     
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Figure 4.1. Frequency of autism-related stories by year.  
 
 
 
For comparison to other content analyses of autism media coverage of the vaccine/autism 
controversy, an analysis was run to establish whether stories mentioning or focusing on vaccines 
as a cause of autism by year, increased, decreased, or remained relatively stable during the study 
period. Figure 4.2 shows there was an increase from 2001(N=1) to 2002 (N=5) (similar to the 
overall increase in autism-related stories). There was also an increase from 2004 (N=4) to 2005 
(N=7); a decrease from 2005 (N=7) to 2006 (N=2), followed by an increase in 2007 (N=7). 
Stories mentioning or focusing on vaccines as a potential cause of autism peaked in 2008 
(N=10).   
Figure 4.2. Frequency of autism stories mentioning or focusing on vaccines by year. 
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 Research question 1b addressed whether the placement of autism-related television 
evening news stories had become more prominent, less prominent, or remained relatively the 
same during the study period. As seen in Table 4.1, more than three-fourths of autism-related 
stories were either a lead story (N=10, 8.3%), occurred before the first commercial or were the 
lead story after the first commercial break (N=51, 42.1%), or were the lead story after any other 
commercial break (N=31, 25.6%). Only 29 stories (24%) did not have a prominent placement. 
Table 4.1. Frequency of autism-related story by placement in broadcast.  
  Placement Frequency Percentage 
 Lead story 10 8.3% 
 Before first commercial or lead story after first commercial 51 42.1% 
 Lead story after any other commercial 31 25.6% 
  Last story 10 8.3% 
  Other (defined as placement anywhere not included above) 19 15.7% 
 
As the number of autism-related stories increased, the placement has remained relatively 
the same; however, there are some notable points in time where placement did change. From 
1994 to 2006, there were no lead stories featuring autism. In 2007, autism-related stories were 
the lead story 7 times. That number has declined since that time, with only 3 additional lead 
news stories on autism. The majority of autism-related stories  between 1994 and 2010 appeared 
before the first commercial break or were the lead story immediately after the break. From 1994 
to 2004, autism-related stories presented before the first commercial break or lead story after the 
first commercial break ranged between 0 to 2, but in 2005, that number jumped to 7. From 2007 
to 2009, autism-related stories were presented before the first commercial break or were the lead 
story after the first commercial break in at least 10 broadcasts per year. Research question 1c 
addressed whether there were significant differences between the networks regarding length of 
story as well as placement. Analysis using a one way analysis of variance (ANOVA) revealed no  
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significant differences between the networks regarding length of story, F(2, 118) = .173, p = 
.842. Analysis using a chi-square test revealed no significant difference between the networks 
regarding story placement, X2 (8) = 4.90; p=.768. 
Autism Causes and Risk Factors 
The second set of research questions was designed to understand which potential causes 
of autism have received the most coverage and how they were framed. Research question 2a 
addressed the frequency that autism-related stories included a discussion of potential causes. Out 
of 121 stories, 61.2% (N=74) addressed causes. Of these stories that included causes, 78.4% 
(N=58) focused on causes as the main topic, where as 21.6% (N=16) just mentioned the causes 
within the story, but cause(s) was not the main focus of the story. 
 Research question 2b asked what causes were addressed the most frequently in autism-
related stories. As shown in Table 4.2, when causes were included in autism-related stories 
(N=74), 68.9% (N=51) discussed vaccines, the most discussed of all causes. Genetics or genes 
was included in 35.1% (N=26) of the stories and environment was discussed as a potential cause 
in 21.6% of the stories (N=16). No other cause was mentioned in more than 10% of the stories 
that mentioned causes. It should be noted that out of all autism-related stories (N=121), 42.1% 
(N=51) either mentioned or focused on vaccines as a cause for autism.  
Table 4.2. Frequency that specific causes were identified within stories that identified potential 
causes of autism.  
Cause Frequency Percentage of stories 
that mentioned a cause 
Vaccines 51 68.9% 
Genetics/Genes 26 35.1% 
Environment 16 21.6% 
Brain irregularities 4 5.4% 
Medications 0 0 
Prenatal Exposures to Viruses 0 0 
Other 6 8.1 % 
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Research question 2c asked when an autism-related story includes one cause, how often 
are other causes mentioned? Out of 121 stories focusing on autism, 51 discuss vaccines as a 
potential cause. Out of 51 stories discussing vaccines as a potential cause, 80.4% (N=41) of 
stories did not mention any other causes; 13.7% (N=7) mentioned one other cause; 5.9% (N=3) 
mentioned two other causes. When genes were mentioned as a potential cause (N=26), genes was 
included by itself with no other causes in 53.8% of stories (N=14), with one other cause in 38.5% 
of stories (N=10), and with two other causes in 7.7% of stories (N=2). The two causes most 
frequently discussed in the same news story were genes and environment (N=11). Genes and 
vaccines (N=9) and vaccines and environment (N=8) were also mentioned together.  
Research question 2d addressed how each cause was most frequently presented: as likely, 
unlikely, or not enough is known to determine if it is a cause. As shown in Table 4.3, when 
vaccines were included in a story (N=51), they were framed as unlikely to be a cause of autism in 
54.9% (N=28) of the stories, likely to be a cause of autism in 19.6% (N=10) of the stories, and 
that there is not enough known to determine whether or not it is a cause in 25.5% (N=13) of the 
stories. These results show that while most stories framed vaccines as unlikely to cause autism, 
nearly half of the stories that mentioned vaccines suggested that they could potentially be a cause 
or that more information is needed. When genes were included in a story (N=26), the majority of 
stories (80.8%) framed genes as a likely cause of autism, while no stories presented it as 
unlikely. This is consistent with the scientific community, where most agree that genes are a 
likely cause of autism (NIH, 2009). That 75% (N=12) of the stories about environmental causes 
(N= 16) of autism suggest that more information is needed is not surprising, given that while 
scientists agree that there are environmental factors that contributes to causing autism, there 
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needs to be more research to determine which environmental factors may cause autism, making 
it a current research priority.  
Table 4.3. Frequency that when a cause is included in a story, it is presented as a likely cause, an 
unlikely cause, or that more information is needed to determine if it is a cause of autism. 
(Percentages within stories about each cause).  
Vaccines Frequency Percentage 
Story suggests the cause is unlikely 28 54.9% 
Story suggests the cause is likely 10 19.6 
Story suggests not enough is known  13 25.5 
Genetics/Genes   
Story suggests the cause is unlikely 0 0  
Story suggests the cause is likely 21 80.8 
Story suggests not enough is known  5 19.2 
Environment   
Story suggests the cause is unlikely 0 0  
Story suggests the cause is likely 4 25.0 
Story suggests not enough is known  12 75.0 
Brain   
Story suggests the cause is unlikely 0 0  
Story suggests the cause is likely 3      75.0 
Story suggests not enough is known  1 25.0 
Other   
Story suggests the cause is unlikely 0 0  
Story suggests the cause is likely 0 0 
Story suggests not enough is known  6 100.0 
 
Research question 2e asked if the framing of vaccines as a likely cause of autism 
increased, decreased, or remained relatively stable during the study period. As seen in figure 4.3, 
2004 saw an increase in stories suggesting vaccines are a likely cause of autism (2003: N= 1; 
2004: N= 4), whereas no stories suggested that it was unlikely that vaccines cause autism or that 
not enough is known or is it inconclusive whether vaccines cause autism. In 2005, there was an 
increase in stories suggesting it was unlikely vaccines cause autism, whereas no stories presented 
the cause as likely, and a few (N=3) suggested that not enough is known or is inconclusive. From 
2007 to 2010, there was a marked increase in the number of stories suggesting that it is unlikely 
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that vaccines cause autism (2007: N= 5; 2008: N=6; 2009: N=6; 2010: N=4), whereas the number 
of stories suggesting the cause was likely dropped to zero, with the exception of 2008 (N=3) and 
the number of stories suggesting that not enough is known or it is inconclusive about whether 
vaccines cause autism remained relatively the same (2007: N=2; 2008: N=1; 2009: N=1; 2010 
N=0).  
Figure 4.3. Frequency that stories framed vaccines as a likely, unlikely or that not enough is 
known to determine it as a cause of autism by year.  
 
 
Research question 2f asked whether the frequency of vaccine–related autism stories 
varied significantly between the networks (ABC, CBS, or NBC) during the study period. 
Analysis using a chi-square test revealed no significant difference in the frequency of vaccine-
related autism stories between the networks, X2 (2) = 2.08; p=.353. CBS either mentioned or 
focused on vaccines as a potential cause of autism (framed as likely, unlikely or inconclusive) 21 
times, NBC 19 times and ABC 11 times. Research question 2g asked whether there was a 
significant difference in the frequency that the networks (ABC, CBS, or NBC) framed vaccines 
0
1
2
3
4
5
6
7
19
94
19
95
19
96
19
97
19
98
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
 (J
an
 -
A
pr
il)
Story suggests the cause is 
unlikely
Story suggests the cause is 
likely
Story suggests not enough is 
known or is inconclusive
60 
as a likely of autism. For the purpose of this analysis the number of stories indicating vaccines 
were likely a cause of autism were compared to those that presented an alternative framing (e.g., 
as either unlikely to cause autism or that more information is needed to determine if it is a 
cause). Analysis using a chi-square test revealed a significant difference in the frequency that the 
networks framed vaccines as a likely cause of autism, X2 (2) = 8.195; p=.017. In the stories that 
discussed vaccines as a cause, ABC never suggested the cause was likely, CBS suggested the 
cause was likely in 28.6% (N=6) of its stories, and NBC suggested the cause was likely in 21.1% 
(N=4) of its stories. ABC suggested vaccines was unlikely to be a cause of autism or more 
information was needed to determine if vaccines are a cause in all (N=11) of its stories about 
vaccines, CBS suggested the cause was unlikely or more information was needed in 71.4% 
(N=15) of its stories about vaccines, and NBC suggested the cause was unlikely or more 
information was needed in 76.4% (N=15) of its stories about vaccines. The results show that of 
all the networks, CBS suggested that vaccines were likely a cause of autism more often than the 
others and ABC the least often.  
Autism Prevalence and Rates 
 The third set of research questions was designed to examine what prevalence numbers, 
rates, or statistics the media used in describing the number of people with autism, when they 
were used, and how they were framed. Out of 121 stories, 46.3% (N=56) included statistics or 
estimates about the number of people with autism or the prevalence of autism. Research question 
3a addressed what rates or statistics the media used in describing the number of people with 
autism each year. As seen in Figure 4.4,  in stories that presented rates or prevalence of autism, 1 
in 166 was presented 12 times during the study period, and was first cited in 2005; 1 in 150 was 
presented 18 times during the study period, and was first cited in 2007, when the data was 
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released; 1 in 90/91 was only cited 2 times, in 2009 when the data was released; 1 in 110 was not 
cited at all despite its release in 2009 as a follow up to the 1 in 150 prevalence rate. The results 
show that out of 56 stories including rates or prevalence of autism, 83.9% (N=47) used “other” 
rates or numbers differing from the numbers that were coded, most notably in 2007, when CDC 
released the 1 in 150 prevalence estimates for the U.S. and 2009, when HRSA and CDC released 
additional prevalence estimates.  
Figure 4.4. Frequency of prevalence, rates of autism included in autism-related stories, per year. 
 
Research question 3b addressed whether the prevalence of autism was framed as increasing; 
33.1% (N=40) of stories characterized autism as increasing. As shown in Figure 4.5, 1997 was 
the first year autism was characterized as increasing. 2007 had the highest number of stories 
characterizing autism as increasing (N=9), the year that CDC released its 1 in 150 prevalence 
data. Prior to that time, 2002 and 2004 had 4 stories each characterizing autism as increasing and 
2005 and 2006 had 5 stories each characterizing autism as increasing. Analysis using a chi-
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increasing, X2 (2) = 2.05; p=.359. Of the 40 stories that framed autism as increasing, 15 appeared 
on CBS, 14 on NBC, and 11 on ABC.  
Figure 4.5. Frequency of stories characterizing autism as increasing by year.  
 
Research question 3c addressed whether autism was framed as an epidemic; 9.1% (N=11) 
of stories characterized autism as an epidemic. As shown in Figure 4.6, 2002 was the first year 
autism was characterized as an epidemic (N=1). The number of stories framing autism as an 
epidemic increased in 2004 (N=2), peaked in 2005 (N=4), and slightly decreased in 2006 (N=3). 
Only 1 story characterized autism as an epidemic in 2007, the year CDC released its 1 in 150 
prevalence data. Analysis using a chi-square test revealed no significant difference in the 
frequency that the networks framed autism as an epidemic, X2 (2) = 3.26; p=.196. Of the 11 
stories framing autism as an epidemic, six appeared on NBC, three on CBS, and two on ABC. 
Research question 3d addressed whether autism was being framed as a public health concern; 
2.5% (N=3) of stories characterized autism as a public health concern. It was characterized as a 
public health concern once in 2004, once in 2007 (the year CDC called autism a “public health 
concern”), and once in 2009.  
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Figure 4.6. Frequency of stories characterizing autism as an epidemic by year.  
 
Sources 
 The fourth set of research questions was designed to examine who the media interviews 
in news stories about autism. Research question 4a addressed what category of people were most 
frequently interviewed in autism-related television evening news stories. Those individuals who 
were interviewed could be coded into multiple categories. Out of all 121 stories, there were a 
total of 301 people interviewed. A separate data set was created so that each person interviewed 
could be treated as a separate case for the analysis in this section. As seen in Figure 4.7, 34.2% 
(N=103) of  individuals interviewed were identified as a parent or family member of a person 
with autism; 12.3% (N=37) of individuals interviewed were identified as a researcher or 
representative from a university; 6.3% (N=19) of individuals interviewed were identified as a 
medical expert affiliated with a hospital; 5.6% (N=17) of individuals interviewed were identified 
as a government health official; 5.3% (N=16) of individuals interviewed were identified as a 
person with autism; 3.3% (N=10) of individuals interviewed were identified as a leader of an 
advocacy or non-profit organization not labeled as a medical expert; 2.7% (N=8) of individuals 
interviewed were identified as a medical expert affiliated with an autism advocacy organization; 
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2% (N=6) of individuals interviewed were identified as a health professional representing a 
health professional organization; 1% (N=3) of individuals interviewed were identified as 
celebrities; and, 28.2% (N=85) individuals were identified as “other,” indicating the person did 
not fit into any of the given categories. Of the 85 individuals interviewed that were identified as 
“other,” a few (N=4) were parents of children who refused to vaccinate their children; a few 
(N=4) were identified as members of congress; several (N=5) were identified as being a part of 
the developmental disabilities research and treatment center called the Kennedy Krieger 
Institute; several (N=6) were medical editors for the networks and were labeled as having 
medical degrees; and, several (N=11) were identified as health professionals, but with no 
affiliation to a health professional organization, advocacy organization, or with the government. 
The majority of the rest of the sources that were coded as “other” were labeled with first and last 
names and no other identifying information in the transcript, either by their name or by their own 
words.  
Research question 4b addressed who most frequently was interviewed in stories that 
mentioned or focused on potential causes of autism. Out of 121 stories, 61.2% (N=74) addressed 
causes. There were a total 195 people interviewed in these 74 stories. As seen in Figure 4.8, of 
the 195 interviews, 34.3% (N= 67) individuals interviewed were identified as a parent or family 
member of a person with autism; 14.4% (N=28) individuals were identified as a researcher or 
representative from a university; 8.2% (N=16) individuals were identified as a medical expert 
affiliated with a hospital; 7.7% (N=15) individuals were identified as a government health 
official; 3.6% (N=7) individuals were identified as a leader of an advocacy or non-profit 
organization, not labeled as a medical expert; 2.6% (N=5) of the individuals were identified as a 
medical expert affiliated with an autism advocacy organization; 2.6% (N=5) of the individuals 
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were identified as a medical expert affiliated with a health professional organization; 1% (N=2) 
of the individuals were identified as a celebrity; and, 26.7% (N=52) of the individuals were 
identified as “other,” indicating the person did not fit into any of the given categories. No stories 
about causes of autism included interviews with individuals who were identified as a person with 
autism.  
Figure 4.7. Frequency of individuals interviewed in all autism-related stories. 
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Figure 4.8. Frequency of individuals interviewed about causes. 
 
Research question 4c addressed who most frequently was interviewed about vaccines. 
Out of 121 stories, 42 focused on vaccines. There were a total of 117 people interviewed in these 
42 stories. As seen in Figure 4.9, of these 117 interviews, 28.2% (N=33) of the individuals were 
identified as a parent or family member of a person with autism; 11.9% (N=14) of individuals 
were identified as a researcher or representative from a university; 11.1% (N=13) of individuals 
were identified as a government health official; 7.6% (N=9) of individuals were identified as a 
medical expert affiliated with a hospital; 3.4% (N=4) of individuals were identified as a medical 
expert affiliated with a health professional organization; 2.6% (N=3) of individuals were 
identified as a leader of an advocacy or non-profit organization, not labeled as a medical expert; 
1.7% (N=2) of individuals were identified as a medical expert affiliated with an autism advocacy 
organization; 1.7% (N=2) individuals were identified as a celebrity; and, 31.6% (N=37) 
individuals were identified as “other,” indicating the person did not fit into any of the given 
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categories. No stories focusing on vaccine as a cause of autism included interviews with 
individuals who were identified as a person with autism.  
Figure 4.9. Frequency of individuals interviewed about vaccines.  
 
Research question 4d asked, of those individuals who were interviewed about vaccines, 
who most frequently presents a case for vaccines as a cause of autism (pro-link) and who most 
frequently makes a case against vaccines being a cause (anti-link). Note, there were some 
individuals interviewed who did not present a case for or against a cause of autism in these 
stories and they were excluded in this analysis. Analysis using non parametric chi-square tests 
for each interview source type revealed: 
· Parents or family members of a person with autism were significantly more likely 
to present a case for vaccines as a cause of autism (pro-link) when interviewed, 
X2(1) = 18.24; p=.000. Of the 29 parents or family members of a person with 
autism presenting an opinion, 89.7% (N=26) were pro-link, while 10.3% (N=3) 
were anti-link.  
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· Government health officials were significantly more likely to present a case 
against vaccines as a cause of autism (anti-link) when interviewed, X2(1) = 7.36; 
p=.007. Of the 11 government health officials presenting an opinion, 90.9% 
(N=10) were anti-link, while 9.1% (N=1) were pro-link.  
· Medical experts from hospitals were significantly more likely to present a case 
against vaccines as a cause of autism (anti-link) when interviewed, X2(1) = 5.44; 
p=.020. Of the 9 medical experts from hospitals presenting an opinion, 88.9% 
(N=10) were anti-link, while 11.1% (N=1) were pro-link. 
· Researchers or representatives from universities were not significantly more 
likely to present a case to present a case for (pro-link) or against (anti-link) 
vaccines as a cause of autism when interviewed, X2(1) = 2.57; p=.109. Of the 14 
researchers or representatives from universities presenting an opinion, 71.4% 
(N=10) were anti-link, while 28.6% (N=4) were pro-link.  
· Leaders of advocacy or non-profit organizations (non-medical) were not 
significantly likely to present either a case for (pro-link) or against (anti-link) 
vaccines as a cause of autism when interviewed, X2(1) = .333; p=.564. Of the 3 
leaders of advocacy or non-profit organizations (non-medical) presenting 
opinions, 66.7% (N=2) were pro-link, while 33.3% (N=1) were anti-link.  
· People identified as “Other” were not significantly more likely to present either a 
case for (pro-link) or against (anti-link) vaccines as a cause of autism when 
interviewed, X2(1) = 2.455; p=.117. Of the 33 identified as “other” presenting 
opinions, 63.6% (N=21) were pro-link, while 36.4% (N=12) were anti-link.  
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· Of the 2 interviews with medical experts from advocacy or non-profit 
organizations, both presented pro-link (N=2) cases.  
· Of the 4 health professionals representing health professional organizations 
presenting an opinion, all (N=4) were anti-link.  
· Of the 2 celebrities presenting an opinion, all (N=2) were pro-link.  
· No people with autism were interviewed about vaccines, therefore no opinions 
about vaccines as a cause were presented.  
The next chapter discusses the findings and limitations of this study as well as suggestions for 
future research and conclusions.  
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CHAPTER 5 
DISCUSSION 
The medical and scientific communities have faced significant challenges in 
understanding and establishing autism as a distinct condition and its causes and risk factors. How 
the public understands this condition and the research conducted thus far via media and other 
sources can have public health implications, as demonstrated in Britain with the increase in 
measles cases (Lewis & Speers, 2003). The increase in measles cases in Britain was a result of 
the decline of measles, mumps, and rubella (MMR) vaccinations, which has been attributed to 
the media’s coverage of the debate over whether the MMR vaccine causes autism (Lewis & 
Speers, 2003). To understand the U.S. media’s contribution to the public discourse on autism, 
this study analyzed television news media coverage using agenda-setting theory and media 
framing concept perspective. Agenda-setting theory provided the framework to examine the 
prominence of autism in evening news broadcasts and media framing scholarship provided the 
framework to examine how these evening news broadcasts characterize certain aspects 
(prevalence and causes) of autism and make them more salient. A content analysis was 
conducted of autism-related stories featured in national television evening news broadcasts airing 
on ABC, CBS, and NBC from 1994, when autism was first recognized as a spectrum disorder in 
the D SM -IV, through April 2010, the time of this study. The data provided a descriptive look at 
how television evening news broadcasts feature autism in terms of salience and framing of 
causes and prevalence.  
Prominence of Autism-related Stories 
 This study captured the prominence of autism-related news stories by examining the 
frequency of stories during the study period, the placement of stories during the study period, 
and the length of stories during the study period. According to the results, autism-related stories 
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have increased over time and have maintained prominent positions within television evening 
news broadcasts. In 2007 the numbers of autism related stories peaked and achieved the most 
prominence by serving as the lead story in several broadcasts. Length of autism-related stories 
remained the same, but the median of 2:01 to 2:30 minutes is more than the average of most 
stories (Watkins, 2001). The analysis suggests that autism has become more salient in television 
evening news over time. There were a total of 121 stories focusing on autism from 1994 through 
April 2010. No television evening news stories focused on autism in 1994, 1995, and 1998. The 
frequency of stories quadrupled from 2001 (N=2) to 2002 (N=12) and nearly doubled from 2006 
(N=14) to 2007 (N=25). The number of autism-related stories in evening news broadcasts peaked 
in 2007, the year CDC released its first multi-site autism spectrum disorder (ASD) prevalence 
data, stating that 1 in 150 eight-year-olds had an ASD. This suggests that the release of the 
prevalence data may have elevated autism as an important issue in the eyes of the media and thus 
for the public.  
Given the controversial nature of the hypothesis that vaccines cause autism, the 
frequency of stories either mentioning or focusing on vaccines during the study period was 
examined for spikes in coverage as well. The results revealed no or low coverage from 1998 to 
2000; increases in coverage from 2001 to 2002 and from 2004 to 2005; a decrease from 2005 to 
2006, followed by an increase in 2007. Stories mentioning or focusing on vaccines as a potential 
cause of autism peaked in 2008. Future qualitative analysis studies of these stories could reveal 
exactly what news items caused the spike in terms of vaccines and autism, but there are a couple 
of points in time worthy of mentioning based on events written about in this study’s literature 
review. In 1998, the Wakefield et al. (1998) study was published in The Lancet, and it did not 
seem to garner any coverage in U.S. television evening news that year. In 1999, the U.S. Food 
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and Drug Administration (FDA) recommended that thimerosal be removed from routine infant 
vaccines in the U.S., but it did not seem to garner much coverage in U.S. television evening news 
that year. In 2001, the Institute of Medicine issued its first report on the hypothesized link 
between the MMR vaccine and autism and it did not seem to generate much coverage in U.S. 
television evening news that year. In Britain, Lewis and Speers (2003) observed that the MMR 
vaccine became controversial between January and September of 2002 because a BBC television 
program, Panorama, aired a broadcast titled “How safe is MMR” on February 3, 2002, taking up 
Wakefield’s theory regarding the MMR vaccine. Wakefield and other colleagues also pre-
published a paper in Molecular Pathology that was made available when this broadcast aired. 
Reporting of a measles outbreak in a middle-class London suburb also highlighted the 
controversy during this period of time. Perhaps, the attention on the subject in Britain generated 
coverage of the debate in the U.S. as well in 2002. Again, a thorough qualitative analysis of the 
broadcast transcripts would reveal what news items garnered attention related to vaccines and 
autism. In 2004, the IOM released their report stating that they had reviewed all scientific 
evidence to date and rejected the causal relationship between autism and the MMR vaccine and 
thimerosal-containing vaccines, which might explain the increase in coverage that year. As for 
2008’s increase in coverage of vaccines and autism, there is nothing in the literature review that 
points to significant events taking place; however, a qualitative analysis study of these stories 
could reveal exactly what news items caused the spike in terms of vaccines and autism. Clarke’s 
(2008) content analysis of U.S. and British newspapers (February 1998 to June 2006), in fact 
found similar results in terms of increasing and decreasing coverage of vaccine/autism stories: 
relatively low coverage of the vaccine/autism controversy from 1998 to 2000, increased attention 
from 2001 to 2002, a spike in articles in 2004, and a steady decline in 2005 and 2006. This 
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suggests that newspapers and evening news coverage are similar in terms of when they increased 
and decreased coverage of autism stories that discuss vaccines.   
Regarding placement in the broadcast, three-fourths of all autism-related stories were 
either a lead story, occurred before the first commercial or were the lead story after the first 
commercial, or were the lead story after any other commercials—considered prominent positions 
within a television evening news broadcast according to the literature review. Over the study 
period, placement remained relatively the same with the exception of two points in time. From 
1994 to 2004, autism-related stories presented before the first commercial or lead story after the 
first commercial ranged from 0 to 2, but in 2005, that number jumped to 7.. From 1994 to 2006, 
no lead story had ever featured autism, but in 2007, autism was featured as a lead story 7 times. 
CDC’s released of its 1 in 150 prevalence data that year would seem to have elevated its 
importance in the eyes of the media. While the length of autism-related stories remained 
relatively the same throughout the study period, the median of two to two and a half minutes was 
more than the average of most stories: one-and-a-half to two minutes (Watkins, 2001) as noted in 
the literature review. There were no significant differences in the frequency of autism-related 
stories between the networks in terms of length of story and placement reveals that the networks 
view autism’s prominence in a similar manner. For the public, they are receiving a consistent 
message from the networks’ evening news coverage: it is an important issue that they should be 
concerned about, especially since 2007.  
This study sought to understand how through selection of news stories, the media focus 
the public’s attention on some issues more than others and influence perceptions about what the 
most important issues are using agenda-setting theory as a framework. This study did not 
compare autism with other issues during the study period to determine its salience relative to 
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other topics, but the increase in the number of stories and increase in the number of stories with 
prominent position within the broadcast indicates that autism has become more salient in 
television evening news stories over time. Therefore, the media’s increasing coverage of autism 
may result in the public’s perception that it is something they should think about. The second-
level of agenda setting, attribute agenda setting, suggests that in addition to the media telling us 
what to think about, they also tell us how to think about some objects. In this framework, the 
results show that the frequency of all stories featuring autism that included vaccines as a cause of 
autism were quite high—nearly half the time. It can be said, then, that the attribute, in this case 
the potential for vaccines causing autism, is salient.  
Autism Causes and Risk Factors 
 As noted in the literature review, scientists are not certain about what causes autism, but 
agree it’s likely that both genetics and environment play a role (NIH, 2009). Some of the most 
controversial hypotheses about causes have concentrated on demonstrating a link between 
vaccines and autism. Considering the media’s effect on the decline of MMR vaccines in Britain 
(Lewis & Speers, 2003) and the recent survey reporting that 1 in 4 U.S. parents believe vaccines 
cause autism, 81% of whom reported that they had heard or read about problems with the MMR 
vaccine (Freed et al., 2010), this investigation sought to understand the media’s contribution to 
the public discourse on potential causes, and how it framed them, especially vaccines. This study 
captured which causes of autism have received the most coverage and whether the media framed 
the causes as likely or unlikely.  
This study found that nearly half of the time that television evening news media report on 
autism, they are associating it with vaccines. The association of autism with vaccines has the 
potential of having an applicability effect. In media framing research, an applicability effect 
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refers to an audience’s acceptance that two concepts are related after exposure to a media 
message that suggests there is a connection between two concepts (Scheufele & Tewksbury, 
2007). Future studies with media audiences could examine whether an applicability effect has 
indeed occurred as a result of television evening news associating autism with vaccines. This 
study also found that stories focusing on causes of autism are not mentioning other scientifically 
accepted causes of autism. The data revealed that vaccines were the only cause discussed in the 
overwhelming majority (80%) of stories that mentioned vaccines. The stories that frame vaccines 
as either unlikely as a cause or suggest that more research is needed to determine if it is a cause 
of autism should at least mention the causes that have been accepted by the scientific 
community, but did not consistently do that. There was an increase after 2004 in stories 
suggesting vaccines were an unlikely cause of autism, which is to be expected given the release 
of the 2004 IOM report rejecting causal relationships between vaccines and autism. However, 
the repetitious association between autism and vaccines, even when framed as unlikely, in 
television evening news could have a potential audience applicability effect, especially when 
other potential causes are not being discussed. Audience research is needed to determine whether 
the public is willing to accept the causes established as more likely by the scientific community. 
For the public, they are receiving a consistent message from the networks’ evening news 
coverage: autism and vaccines are an important issue that they should be concerned about.  
The National Institutes of Health’s (NIH) (2009) stated that it is likely that both genetics 
and some environmental factor(s) play a role in causing autism. The data revealed the two causes 
most frequently discussed together were genes and environment. Stories that discussed genetics 
as a potential cause always presented it as likely or that more research was needed. The fact that 
no story framed genetics as an unlikely cause of autism was an interesting finding when 
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compared to vaccines (which were framed as a likely cause in almost half the stories) and speaks 
to the controversial nature of the hypothesis that vaccines cause autism: because it is 
controversial it will receive more coverage than something than is not controversial. 
The analysis revealed no significant difference in the frequency of vaccine-related autism 
stories between the networks. The public is receiving a consistent message from the networks’ 
evening news coverage: autism and vaccines are an important issue that they should be 
concerned about. However, there was a significant difference in the frequency that the networks 
(ABC, CBS, or NBC) framed vaccines as a likely of autism. : ABC was significantly less likely 
to frame vaccines as a cause of autism (no pro-link stories appeared on the network) as compared 
to CBS and NBC.  
Autism Prevalence and Rates 
 This study also examined what prevalence numbers, rates, or statistics the media used in 
describing the number of people with autism by year and how the number of people with autism 
or the prevalence of autism was framed. The results showed that the majority of stories 
mentioning prevalence rates cited numbers that had not been identified in the literature review. 
One third of stories framed autism as increasing regardless if data were cited. Furthermore, 
television evening news has not significantly contributed to the framing of autism as an 
epidemic. In terms of the rates or statistics used by the media, the one in 166 prevalence data 
(Fombonne, 1999) was presented 12 times during the study period; it was first cited by television 
evening news in 2005 and Fombonne published the data in 1999. Another noteworthy finding 
was that CDC’s one in 150 prevalence data was presented 18 times during the study period, and 
was first cited in 2007, when the data were released. The Health Resources and Services 
Administration (HRSA) study reporting one in 90 children had autism was included in two 
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stories in 2009, the time of its release. CDC’s one in 110 prevalence data was published in 2009 
after HRSA’s data release, as a follow up to the 2007 prevalence report of one in 150, but 
received no coverage despite that its methods (use of clinical and education records) are more 
highly regarded than those used in the HRSA study (a survey of parental reports), although they 
are considered to be complimentary methods of determining the number of people with autism. 
For the media, reporting a prevalence of one in 90 in October and then to turn around and report 
a prevalence of one in 110, perhaps, did not make sense. It suggests that the media feel like they 
have established autism as a prevalent condition and that backtracking and using the CDC’s data 
would have been confusing for the public. Which prevalence data the media uses moving 
forward will prove to be interesting, given that CDC and HRSA are funded to and have plans to 
report on their respective studies again in two years.  
The data also revealed the media’s use of “other” rates of or prevalence of autism was 
quite high (i.e., prevalence rates that differed from the numbers that were coded, which were 
based on published reports cited in the literature). Nearly 84% of stories mentioning prevalence 
rates cited numbers that had not been identified in the literature review, some occurring after 
2007 when CDC established its prevalence rate of 1 in 150. It should be noted that “other” 
numbers coded included state level data (e.g., Oregon and California) and could account for the 
large percentage of pieces that cite “other” prevalence rates. It also speaks to the fact that there 
were no accepted prevalence rates of autism for the U.S. prior to 2007. Given the number of 
“other” numbers cited after 2007, future research should consider how media interpret 
prevalence data. For example, the media may be more comfortable reporting a concrete number 
of people with autism (e.g., 1.2 million) versus reporting it as a one in 110 or one in 90. Future 
studies should also examine autism advocacy organizations and their use of the prevalence data 
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to better understand when and how these numbers have been used to draw attention to autism 
issues.  
 This study also examined how the prevalence data or rates/estimates have been framed by 
the media in terms of whether autism is increasing, an epidemic, or an urgent public health 
concern. The framing of prevalence data can potentially affect government policies and for 
funding autism research and services. Also, by framing it as increasing over the same years that 
the number of required vaccinations has increased, then the argument for a vaccination-autism 
connection may be strengthened. The data revealed that one third of stories framed autism as 
increasing regardless if data were cited. Very few stories framed autism as an epidemic (most 
occurring around 2006, before CDC established prevalence data) and even fewer framed autism 
as a public health concern. While one third of stories framed autism as increasing, it appears that 
television evening news has not significantly contributed to the framing of autism as an 
epidemic. That only a couple of stories framed autism as a public health concern reveals that 
television evening news has not adopted the CDC’s frame.  
Sources 
Because journalists tell stories primarily through those who have authoritative personal 
knowledge of an event (Singer & Endreny, 1993), this study also examined who the media 
interviewed in news stories about autism. Ultimately, this study found that television evening 
news has framed the issue of vaccines causing autism as one where parents/family members of 
children with autism believe that autism is caused by vaccines and where the medical 
establishment does not believe that autism is caused by vaccines. These findings suggest that the 
audience has to determine who they trust more –parents/family members of children with autism 
or the government and medical community. 
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Parents or family members of people with autism were most frequently interviewed in 
television evening news stories about autism. In this case parents or family members of a person 
with autism have authoritative personal knowledge of autism and it would serve to reason that 
they are most interested in autism issues. This research revealed that when interviewed, parents 
of children with autism were significantly more likely to present a case for vaccines as a cause of 
autism than against it. Government health officials and medical experts from hospitals were 
significantly more likely to present a case against vaccines as a cause of autism than for it. 
Health professionals from health professional organizations presented a case against vaccines as 
a cause of autism every time they were interviewed on the subject. This analysis reveals that 
television evening news has framed this issue of vaccines causing autism as one where parents or 
family members of children with autism nearly always side with the non-scientifically accepted 
views that autism is caused by vaccines even though more than half of the stories frame vaccines 
as an unlikely cause. It is troubling that television evening news continued to cover  the 
vaccine/autism issue even after the 2004 IOM report declared vaccines were not a cause of 
autism, considering that the majority of the medical and scientific communities have accepted 
that it is not a cause. Perhaps advocacy groups and parents of children with autism who continue 
to believe that there is a link are framing their messages in a more compelling way than the 
government and medical establishment. Future research should include a content analysis of 
materials, Web pages, and other texts from these advocacy groups as well as a quantitative study 
of the knowledge, attitudes and beliefs of parents of children with autism to determine what 
messages are resonating with them. This analysis also revealed that celebrities were not often 
interviewed in television evening news stories about autism. Jenny McCarthy, a celebrity and 
mother of a child with autism, has become a pseudo-spokesperson for the belief that vaccines 
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cause autism, yet television evening news has not featured her in this way. Future research 
should include a content analysis of daytime and primetime talk shows as well as morning news 
shows where celebrities are more likely to be interviewed.  
Limitations of the Study 
 A significant limitation of this study was that it examined only the television evening 
news transcripts as opposed to viewing the broadcasts in addition to the transcripts. Viewing the 
broadcasts would have allowed the author to code for items featured in video footage such as 
children with autism or children being vaccinated. Coding video footage would enable 
researchers to better understand how broadcasts are telling the story of autism.  
 Another limitation of this study is its examination of one particular category of television 
program: the evening news. A recent survey conducted by Pew (2008) showed that 29% of 
respondents reported watching nightly network news, but that still leaves about two-thirds of 
[insert who was the focus – US adults?] who are not exposed to the news messages through these 
channels. That does not mean that more people were not exposed to these news messages. 
Networks have multiple formats for their programming and often times repeat stories in those 
various formats. Examining a network’s morning news shows, primetime news magazine shows, 
and network websites could provide a more complete picture of how autism is framed and 
through these networks. Also examining cable news outlets for their evening news coverage of 
autism would provide a more complete picture of what message U.S. adults are receiving on 
television news programs. Unfortunately, transcripts were not available for the entire study 
period in order to conduct a complete content analysis. Having transcripts for cable news shows 
would have enabled the study to provide a more complete picture of how television news frames 
autism causes and prevalence. 
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 This study could have provided more descriptive information about how autism stories 
were framed through a qualitative examination of stories. In addition to coding for specific items, 
a thorough reading of the transcripts would have revealed, what topics related to vaccines 
causing autism were garnering coverage (e.g., MMR vaccine, thimerosal, or number of 
vaccines).    
 Finally, this study only examined the framing of two autism-related issues: causes and 
prevalence. Certainly, there are other issues that warrant analysis and have received media 
attention: early identification, treatment, and services. Examining these issues would have 
presented a more complete picture of how the media frames autism overall.  
Suggestions for Future Research 
The purpose of this study was to conduct a content analysis to understand how television 
news media framed autism causes and prevalence and contributed to the public discourse on 
these issues from 1994, when autism was first recognized as a spectrum of disorders in the DSM-
IV, through April 2010. In order to provide a more complete picture of how mass media frame 
autism causes and prevalence, researchers could conduct a content analysis of other television 
news programming on the major networks, including their morning news shows as well as their 
primetime newsmagazine shows. Doing so would allow a better comparison of how the 
individual networks frame autism-related issues. A content analysis of cable news shows such as 
CNN and FOX would be helpful as well. Aside from network and cable shows, researchers 
should consider analyzing talk shows such as “Oprah,” “The View,” or “The Doctors,” which 
feature health  topics.  Researchers should also conduct a content analysis of newspaper and 
online coverage using a similar coding scheme to compare how other media frame these issues. 
An examination of press releases released by autism advocacy organization might provide 
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further understanding of how these issues are framed. A complete content analysis of all mass 
media and autism advocacy organizations press releases should lay the foundation for additional 
media effects research to understand, what, if any, role U.S. mass media plays in influencing 
beliefs, attitudes, intentions, or behaviors of audiences in relation to autism. Conducting media 
effects research with audiences using surveys, experiments, focus groups, or in-depth interviews 
will also provide a true sense of whether salience has been transferred from the media to the 
audience, a key component of agenda-setting theory.  
Conclusion 
This study advances the scholarship on agenda setting and media framing by examining 
the salience of autism and related topics and addressing the news media’s portrayal of autism 
causes and prevalence. The study examined the frequency of these autism-related issues from 
1994 through the first few months of 2010 to better understand how television evening news 
framed autism and whether the networks differed in their coverage and framing of autism. The 
data show that autism has become increasingly salient in television evening news. Furthermore, 
the data revealed that coverage of the vaccines/autism controversy is a salient issue in television 
evening news. They also show there were no significant differences between the major networks 
(ABC, CBS, and NBC) in terms of how frequently they covered autism-related stories, the 
median length of those stories or the placement in the broadcast (prominent). There was a 
significant difference in the frequency that the networks framed vaccines as a likely cause of 
autism. The results showed that ABC never framed vaccines as a likely cause of autism in any of 
their coverage of the topic during the study period as compared to CBS and NBC, whose 
network news programs said it was a likely cause of autism in roughly 21 to 28% of their stories. 
The majority of news stories tended to frame vaccines as an unlikely cause of autism, but they 
also tended to include interviews with parents who believe that vaccines cause autism. The 
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medical establishment was more likely to present the case for vaccines not causing autism, which 
means that the audience has to determine who they trust more – other parents or the government 
and medical community. The major networks ultimately frame autism causes and prevalence in 
similar ways, providing some dominant frames for the public that should be examined in terms 
of interpretation and effects. In the U.S., it is important for health communicators interested in 
autism to examine the interpretation and effects of these dominant frames because of the public 
health implications, especially regarding vaccines. Health communicators should use this study’s 
findings and future audience effects research to develop strategies that ensure accurate 
information about autism is communicated to the media and other channels that resonate with the 
public. 
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APPENDIX A: CONTENT ANALYSIS CODEBOOK 
 
Television Evening News Transcripts 
Content Analysis Codebook 
 
Please read carefully all directions for coding each item. For reliability reasons, once you start 
the coding process, there will be no time for more questions and discussions. Make sure to 
address all your questions BEFORE you start coding. When coding, please be advised to read 
the entire transcript before coding. Please write your initials in the top right hand corner of the 
code sheet.  
 
1. Transcript ID 
 
Directions:  Write down the transcript ID number, which can be found at the top right-hand 
corner of first page: Vanderbilt Television News Archive.  
 
_______________ 
 
 
2. Network  
 
Directions: Look at the first page: Vanderbilt Television News Archive. Which network did the 
story appear on? (Circle one) 
 
0) ABC  1) CBS   2) NBC 
 
 
3. Year of the story 
 
Directions: Look at the first page:  Vanderbilt Television News Archive and write down the 
year of the story. For example, if the year is 1996, write 1996. 
Year:  
 
 
4. Story length/Time spent on story 
 
Directions: Look at the first page:  Vanderbilt Television News Archive Summary Look for the 
text that says Program Time. To the right of Program Time, you will see the word Duration. It 
will be written in minutes and seconds. Circle one below.  
 
 
0). 0 to 00:30 
 
1). 00:31 to 01:00 
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2). 01:01 to 01:30 
 
3). 01:31 to 02:00 
 
4). 02:01 to 02:30 
 
5). 02:31 to 03:00 
 
6). 03:01 to 03:30 
 
7). 03:31 to 04:00 
 
8). 04:01 to 04:30 
 
9). 04:31 to 05:00 
 
10). Longer than 05:01  
 
 
6. Broadcast placement 
 
Directions: Look at the second page titled: Vanderbilt Television News Archive. At the top of 
the page, the title should say “Television News Archive: Display Complete Broadcast.” Find 
summary of the story about autism highlighted in yellow on the page. Is it the lead story 
(defined as first story); Before the first commercial or lead story (first story) after the first 
commercial; lead story (first story) after any other commercial; last story; or other (defined as 
placement anywhere not included in the above places). Please circle one:  
 
Placement in broadcast: 
 
0). Lead story (defined as first story) 
 
1). Before the first commercial or lead story (first story) after the first commercial  
 
2). lead story (first story) after any other commercial 
 
3). Last story  
 
4). other (defined as placement anywhere not included in the above places)  
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7. Topics Covered in Autism Story: Cause(s) 
 
 
 Directions: Following the “Vanderbilt Television News Archive Display Complete Broadcast” 
pages, you will find a transcript of a news story. Read the transcript. Does the story discuss or 
mention causes, risk factors, or potential causes or risk factors for autism?  
 
Circle   0). No         or     1). Yes 
 
Note: If 1) Yes is circled, please continue with Question 6a. Otherwise, skip to Question 7.  
 
6a. Is the main focus of the story about causes, risk factors, or potential causes or risk 
factors for autism? Or does it mention causes, risk factors, or potential causes or risk 
factors for autism? 
 
Directions: Circle one. 
 
0). Causes/risk factors for autism were mentioned in the story, but not the main focus. 
This is defined as not being the main focus of the story, but mentioned somewhere within the 
story.  
 
1). Causes/risk factors for autism were the main focus of the story 
This is defined as being discussed throughout the story and is the main focus and point of the 
story.  
 
 
6b. Specify whether each cause or risk factor of autism was not included, mentioned, or was the 
primary focus of the story.  
 
Then, if the cause or risk factor of autism was either mentioned or was the primary focus of the 
story, indicate whether story suggests that it is likely, unlikely, or inconclusive as a cause or risk 
factor for autism  support it as a cause. 
 
 
Directions: For each cause or risk factor circle 
0) not included;   1)  mentioned;   or    2) primary focus of the story 
 
For each cause or risk factor where 1) mentioned or 2) primary focus of the story is 
circled, please circle one: 
0) story suggests that the cause or risk factor is unlikely  
This is defined as the story suggesting that the cause or risk factor is improbable, not 
plausible, disproved, or unsupported by evidence, science or the majority of scientists or 
unsupported by the medical community or the majority of doctors.  
1) story suggests that the cause or risk factor is likely 
This is defined as the story suggesting that the cause or risk factor is probable, plausible, 
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proven, or supported by evidence, science or the majority of scientists or supported by 
the medical community or the majority of doctors.  
2)   story suggests that not enough is known or it is inconclusive as a cause or risk factor 
            This is defined as the story suggesting that not enough is known yet to consider  
            whether it is a cause or risk factor for autism.  
 
A). Genetics or genes:   
Genes or genetic causes may include the words family history or genes from mother or father. 
This could also include the words twins or siblings. This could also include “risk” genes or 
genes that have been identified by scientists as increasing the risk for autism.  
 
0) not included;   1)  mentioned;   or   2) primary focus of the story 
 
 
If 1) mentioned or 2) primary focus of the story is circled, please circle one: 
0) story suggests that the cause or risk factor is unlikely  
 
1) story suggests that the cause or risk factor is likely 
 
2)   story suggests that not enough is known or it is inconclusive as a cause or risk factor 
 
  
B). Brain/Neurological Irregularities:  
This is defined as irregularities in regions of the brain as a cause of autism. This may also 
include abnormal levels of serotonin or other neurotransmitters as a cause of autism. 
 
0) not included;   1)  mentioned;   or   2) primary focus of the story 
 
 
If 1) mentioned or 2) primary focus of the story is circled, please circle one: 
0) story suggests that the cause or risk factor is unlikely  
 
1) story suggests that the cause or risk factor is likely 
 
2)   story suggests that not enough is known or it is inconclusive as a cause or risk factor 
 
 
C). Prenatal Exposure to Viruses: 
This is defined as prenatal exposure to viruses as a cause of autism. Some viruses that may be 
mentioned include cytomegalovirus or CMV and rubella.  
 
0) not included;   1)  mentioned;   or   2) primary focus of the story 
 
 
If 1) mentioned or 2) primary focus of the story is circled, please circle one: 
0) story suggests that the cause or risk factor is unlikely  
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1) story suggests that the cause or risk factor is likely 
 
2)   story suggests that not enough is known or it is inconclusive as a cause or risk factor 
 
D). Medications: 
This may include medications such as, but not limited to, thalidomide, valproic acid, and 
misoprostol.  
 
0) not included;   1)  mentioned;   or   2) primary focus of the story 
 
 
If 1) mentioned or 2) primary focus of the story is circled, please circle one: 
0) story suggests that the cause or risk factor is unlikely  
 
1) story suggests that the cause or risk factor is likely 
 
2)   story suggests that not enough is known or it is inconclusive as a cause or risk factor 
 
E). Vaccines: 
This includes vaccines, such as, but not limited to, the vaccine for Measles, Mumps, and 
Rubella or MMR; thimerosal, a preservative in vaccines; and/or the number of vaccines as a 
cause of autism.  
 
0) not included;   1)  mentioned;   or   2) primary focus of the story 
 
 
If 1) mentioned or 2) primary focus of the story is circled, please circle one: 
0) story suggests that the cause or risk factor is unlikely  
 
1) story suggests that the cause or risk factor is likely 
 
2)   story suggests that not enough is known or it is inconclusive as a cause or risk factor 
 
 
F). Environment: 
This may include something in the environment can cause autism. This includes using the word 
“environmental” or “environment” and/or toxins, chemicals, pollutants or pesticides.  
 
0) not included;   1)  mentioned;   or   2) primary focus of the story 
 
 
If 1) mentioned or 2) primary focus of the story is circled, please circle one: 
0) story suggests that the cause or risk factor is unlikely  
 
1) story suggests that the cause or risk factor is likely 
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2)   story suggests that not enough is known or it is inconclusive as a cause or risk factor 
 
G). Other: 
 
Other is defined as a cause of autism not on this list.  
 
0) not included;   1)  mentioned;   or   2) primary focus of the story 
 
If you circled other, please write the cause in this space: 
_____________________________________ 
 
If 1) mentioned or 2) primary focus of the story is circled, please circle one: 
0) story suggests that the cause or risk factor is unlikely  
 
1) story suggests that the cause or risk factor is likely 
 
2)   story suggests that not enough is known or it is inconclusive as a cause or risk factor 
 
 
7. Topics Covered in Segment on Autism: Estimates/Prevalence  
 
 
Directions: Does the segment present statistics or estimates about the number of people with 
autism or the prevalence of autism?  Prevalence is a measure of the number of cases of a disease 
or condition in a defined group of people over a defined period of time and is usually given in 
this manner 1 in 10 people have xxxx condition.  
Circle one 
0). No         or     1). Yes 
 
Note: If 1) Yes is circled, please continue with Question 7a. Otherwise, skip to Question 8. 
 
 
7a. How many statistics or estimates  of the number of people with autism or prevalence 
rates are mentioned in the story? 
 
Directions: Write how many different statistics or estimates of the number of people with 
autism or the prevalence rates of autism are mentioned in the story (1, 2, 3, 4….) below. 
 
_________________ 
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7b. Is the main focus of the story about data presenting statistics/estimates or prevalence 
of autism? Or does it just mention the data? 
 
Directions: Circle one answer.  
 
0). Statistics/estimates or prevalence of autism is mentioned in the story, but not the main 
focus. 
This is defined as not being included in the leading paragraph or sentences/or in the headline, 
but mentioned somewhere else in the story. 
 
1). Statistics/estimates or prevalence of autism is the main focus of the story 
This is defined as being discussed in the leading paragraph or sentences and/or in the headline 
of the transcript and may include the words “new data” or “new numbers.”  
 
 
7c. According to the news story, what is the prevalence of autism or what is the statistic or 
estimate given regarding the number of people with autism? 
 
 
Directions: Circle the statistic/estimate or prevalence numbers provided by the news story. 
Please circle or write in the exact number that appears in the story. You do not need to make 
any calculations.  
 
 
1. 4.5 per 10,000  
2. 67 per 10,000  
3. 60 per 10,000  
4. 1 in 166  
5. 1 in 150  
6. 1 in 90 or 1 in 91 
7. 1 in 110  
8. 1% or 1 percent  
9. other: please enter number mentioned_______________ 
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7d. Does the story indicate whether the autism rates are increasing or growing? 
 
Directions: Does the story indicate whether the rates of people with autism are increasing or 
growing? Circle 
 
0). No         or     1). Yes 
 
 
8. Is autism identified as an “epidemic” in the news story? 
 
Directions: Is autism identified as an “epidemic”? [story uses this word specifically with regard 
to autism]. Circle  
 
0). No         or     1). Yes 
 
 
9. Is autism identified as an “urgent public health concern” or a “public health concern” or a 
“public health problem”? 
 
Directions: Is autism identified as an “urgent public health concern” or a “public health 
concern” or a “public health problem” or a “public health danger” or a “public health 
concern”? [story uses one of these phrases with regard to autism]. Please circle  
 
0). No         or     1). Yes 
 
 
10. Was anyone interviewed for the segment? 
 
 
Directions: Is anyone interviewed for the segment? Circle 
 
0) No         or     1). Yes 
 
 
Note: If 1) Yes is circled, please complete Question 10(a) for each different person who is 
interviewed. If not, the coding for this transcript is complete 
 
 
10a. Who is interviewed for the segment? Person 1.  
 
 
Directions:  
Person 1: This refers to the first person interviewed. Circle all that apply. For example, if the 
person interviewed is a parent of a child with autism and is identified as associated with an 
advocacy organization, circle both. A person must be actually interviewed and speaking, not 
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just shown. 
 
1. Government Medical/Scientific Expert  
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist 
who is identified as currently a part of state government or national government agency such as 
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), 
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services 
(HHS), or the U.S. Food and Drug Administration (FDA).  
 
2. Medical Expert from a Hospital  
A medical/scientific expert from a hospital could be a doctor or a nurse or another health 
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a 
hospital.  
 
3. Medical Expert from an autism advocacy organization 
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or 
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of 
America. The expert is identified with an autism advocacy organization. 
 
4. Medical Expert from a health care professional organization 
A medical/scientific expert from a health care professional organization is defined as a doctor, 
nurse, therapist, psychologist from an organization such as the American Academy of 
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing. 
The expert is identified with a health care professional organization. 
 
5. Person with autism 
 
6. Parents of or family member of a person with autism 
 
7. Celebrity 
A celebrity is defined as a person who is identified as an entertainer or in the entertainment 
industry such as an actress/actress, singer, reality television star, etc…This also may include 
professional athletes such as a basketball or football player. If a celebrity is interviewed, please 
list that person’s name on the line below:  
 
_____________________________ 
 
8. Leader or someone associated with an advocacy organization. 
This is defined as anyone associated with an advocacy organization who is not explicitly 
defined as a medical/scientific expert who works at an advocacy organization such as Autism 
Speaks, Cure Autism Now, Autism Society of America, etc… 
 
9. Other 
Please list any other identifying information for the first person interviewed that do(es) not fit 
into a category from above: 
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____________________________________________________  
 
 
Note: If another person is interviewed, please proceed to question 10(b). If not, please proceed 
to question 11. 
 
 
10b. Who is interviewed for the segment? Person 2.  
 
 
Directions:  
Person 2: This refers to the second person interviewed. Circle all that apply. For example, If 
the person interviewed is a parent of a child with autism and is identified as associated with an 
advocacy organization, circle both. A person must be actually interviewed and speaking, not 
just shown. 
 
1. Government Medical/Scientific Expert  
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist 
who is identified as currently a part of state government or national government agency such as 
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), 
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services 
(HHS), or the U.S. Food and Drug Administration (FDA).  
 
2. Medical Expert from a Hospital  
A medical/scientific expert from a hospital could be a doctor or a nurse or another health 
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a 
hospital.  
 
3. Medical Expert from an autism advocacy organization 
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or 
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of 
America. The expert is identified with an autism advocacy organization. 
 
4. Medical Expert from a health care professional organization 
A medical/scientific expert from a health care professional organization is defined as a doctor, 
nurse, therapist, psychologist from an organization such as the American Academy of 
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing. 
The expert is identified with a health care professional organization. 
 
5. Person with autism 
 
6. Parents of or family member of a person with autism 
 
7. Celebrity 
A celebrity is defined as a person who is identified as an entertainer or in the entertainment 
industry such as an actress/actress, singer, reality television star, etc…This also may include 
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professional athletes such as a basketball or football player. If a celebrity is interviewed, please 
list that person’s name on the line below:  
 
_____________________________ 
 
8. Leader or someone associated with an advocacy organization. 
This is defined as anyone associated with an advocacy organization who is not explicitly 
defined as a medical/scientific expert who works at an advocacy organization such as Autism 
Speaks, Cure Autism Now, Autism Society of America, etc… 
 
9. Other 
Please list any other identifying information for the first person interviewed that do(es) not fit 
into a category from above: 
 
____________________________________________________  
 
 
Note: If another person is interviewed, please proceed to question 10(c). If not, please proceed 
to question 11. 
 
 
10c. Who is interviewed for the segment? Person 3.  
 
 
Directions:  
Person 3: This refers to the third person interviewed. Circle all that apply. For example, if the 
person interviewed is a parent of a child with autism and is identified as associated with an 
advocacy organization, circle both. A person must be actually interviewed and speaking, not 
just shown.  
 
1. Government Medical/Scientific Expert  
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist 
who is identified as currently a part of state government or national government agency such as 
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), 
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services 
(HHS), or the U.S. Food and Drug Administration (FDA).  
 
2. Medical Expert from a Hospital  
A medical/scientific expert from a hospital could be a doctor or a nurse or another health 
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a 
hospital.  
 
3. Medical Expert from an autism advocacy organization 
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or 
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of 
America. The expert is identified with an autism advocacy organization. 
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4. Medical Expert from a health care professional organization 
A medical/scientific expert from a health care professional organization is defined as a doctor, 
nurse, therapist, psychologist from an organization such as the American Academy of 
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing. 
The expert is identified with a health care professional organization 
 
5. Person with autism 
 
6. Parents of or family member of a person with autism 
 
7. Celebrity 
A celebrity is defined as a person who is identified as an entertainer or in the entertainment 
industry such as an actress/actress, singer, reality television star, etc…This also may include 
professional athletes such as a basketball or football player. If a celebrity is interviewed, please 
list that person’s name on the line below:  
 
_____________________________ 
 
8. Leader or someone associated with an advocacy organization. 
This is defined as anyone associated with an advocacy organization who is not explicitly 
defined as a medical/scientific expert who works at an advocacy organization such as 
Autism Speaks, Cure Autism Now, Autism Society of America, etc… 
 
9. Other 
Please list any other identifying information for the first person interviewed that do(es) 
not fit into a category from above: 
 
____________________________________________________  
 
 
Note: If another person is interviewed, please proceed to question 10(d). If not, please proceed 
to question 11. 
 
 
10d. Who is interviewed for the segment? Person 4.  
 
 
Directions:  
Person 4: This refers to the fourth person interviewed. Circle all that apply. For example, If the 
person interviewed is a parent of a child with autism and is identified as associated with an 
advocacy organization, circle both. A person must be actually interviewed and speaking, not 
just shown. 
 
1. Government Medical/Scientific Expert  
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist 
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who is identified as currently a part of state government or national government agency such as 
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), 
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services 
(HHS), or the U.S. Food and Drug Administration (FDA).  
 
2. Medical Expert from a Hospital  
A medical/scientific expert from a hospital could be a doctor or a nurse or another health 
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a 
hospital.  
 
3. Medical Expert from an autism advocacy organization 
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or 
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of 
America. The expert is identified with an autism advocacy organization 
 
4. Medical Expert from a health care professional organization 
A medical/scientific expert from a health care professional organization is defined as a doctor, 
nurse, therapist, psychologist from an organization such as the American Academy of 
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing. 
The expert is identified with a health care professional organization 
 
5. Person with autism 
 
6. Parents of or family member of a person with autism 
 
7. Celebrity 
A celebrity is defined as a person who is identified as an entertainer or in the entertainment 
industry such as an actress/actress, singer, reality television star, etc…This also may include 
professional athletes such as a basketball or football player. If a celebrity is interviewed, please 
list that person’s name on the line below:  
 
_____________________________ 
 
8. Leader or someone associated with an advocacy organization. 
This is defined as anyone associated with an advocacy organization who is not explicitly 
defined as a medical/scientific expert who works at an advocacy organization such as Autism 
Speaks, Cure Autism Now, Autism Society of America, etc… 
 
9. Other 
Please list any other identifying information for the first person interviewed that do(es) not fit 
into a category from above: 
 
____________________________________________________  
Note: If another person is interviewed, please proceed to question 10(e). If not, please proceed 
to question 11.  
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10e. Who is interviewed for the segment? Person 5.  
 
 
Directions:  
Person 5: This refers to the fifth person interviewed. Circle all that apply. For example, If the 
person interviewed is a parent of a child with autism and is identified as associated with an 
advocacy organization, circle both. A person must be actually interviewed and speaking, not 
just shown. 
 
1. Government Medical/Scientific Expert  
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist 
who is identified as currently a part of state government or national government agency such as 
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), 
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services 
(HHS), or the U.S. Food and Drug Administration (FDA).  
 
2. Medical Expert from a Hospital  
A medical/scientific expert from a hospital could be a doctor or a nurse or another health 
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a 
hospital.  
 
3. Medical Expert from an autism advocacy organization 
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or 
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of 
America. The expert is identified with an autism advocacy organization. 
 
4. Medical Expert from a health care professional organization 
A medical/scientific expert from a health care professional organization is defined as a doctor, 
nurse, therapist, psychologist from an organization such as the American Academy of 
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing. 
The expert is identified with a health care professional organization. 
 
5. Person with autism 
 
6. Parents of or family member of a person with autism 
 
7. Celebrity 
A celebrity is defined as a person who is identified as an entertainer or in the entertainment 
industry such as an actress/actress, singer, reality television star, etc…This also may include 
professional athletes such as a basketball or football player. If a celebrity is interviewed, please 
list that person’s name on the line below:  
 
_____________________________ 
 
 
104 
8. Leader or someone associated with an advocacy organization. 
This is defined as anyone associated with an advocacy organization who is not explicitly 
defined as a medical/scientific expert who works at an advocacy organization such as Autism 
Speaks, Cure Autism Now, Autism Society of America, etc… 
 
9. Other 
Please list any other identifying information for the first person interviewed that do(es) not fit 
into a category from above: 
 
____________________________________________________  
 
 
 
 
11. For each person interviewed, please indicate whether he/she presents a message that 
suggests that there is no link between autism and vaccines (anti-link) or a message that 
suggests that there is a link between autism and vaccines (pro-link)? 
If the story did not include any mention of vaccines, then you are done coding this story. 
 
Directions: For each person interviewed, were they pro-vaccine or anti-vaccine or not sure?  
 
A). Person 1: 
 
0). Anti-link.  
This is defined as the person being interviewed indicating that vaccines do not cause autism or 
that a link between autism and vaccines was considered improbable, unsupported by evidence, 
or disproved. 
 
1). Pro-link. 
This is defined as the person being interviewed indicating that the theory or idea of vaccines 
causing autism is possible, plausible, or probable.  
 
2). Not sure 
This is defined as the person being interviewed indicating that he/she is conflicted by the theory 
or idea of vaccines causing autism.  
 
3). N/A 
This person does not discuss vaccines. 
 
B) Person 2: 
 
0). Anti-link.  
This is defined as the person being interviewed indicating that vaccines do not cause autism or 
that a link between autism and vaccines was considered improbable, unsupported by evidence, 
or disproved. 
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1). Pro-link. 
This is defined as the person being interviewed indicating that the theory or idea of vaccines 
causing autism is possible, plausible, or probable.  
 
2). Not sure 
This is defined as the person being interviewed indicating that he/she is conflicted by the theory 
or idea of vaccines causing autism.  
 
3). N/A 
This person does not discuss vaccines. 
 
 
C) Person 3: 
 
0). Anti-link.  
This is defined as the person being interviewed indicating that vaccines do not cause autism or 
that a link between autism and vaccines was considered improbable, unsupported by evidence, 
or disproved. 
 
1). Pro-link. 
This is defined as the person being interviewed indicating that the theory or idea of vaccines 
causing autism is possible, plausible, or probable.  
 
2). Not sure 
This is defined as the person being interviewed indicating that he/she is conflicted by the theory 
or idea of vaccines causing autism.  
 
3)  N/A 
This person does not discuss vaccines. 
 
 
D) Person 4: 
 
0). Anti-link.  
This is defined as the person being interviewed indicating that vaccines do not cause autism or 
that a link between autism and vaccines was considered improbable, unsupported by evidence, 
or disproved. 
 
1). Pro-link. 
This is defined as the person being interviewed indicating that the theory or idea of vaccines 
causing autism is possible, plausible, or probable.  
 
2). Not sure 
This is defined as the person being interviewed indicating that he/she is conflicted by the theory 
or idea of vaccines causing autism.  
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3)  N/A 
This person does not discuss vaccines. 
 
E) Person 5: 
 
0). Anti-link.  
This is defined as the person being interviewed indicating that vaccines do not cause autism or 
that a link between autism and vaccines was considered improbable, unsupported by evidence, 
or disproved. 
 
1). Pro-link. 
This is defined as the person being interviewed indicating that the theory or idea of vaccines 
causing autism is possible, plausible, or probable.  
 
2). Not sure 
This is defined as the person being interviewed indicating that he/she is conflicted by the theory 
or idea of vaccines causing autism.  
 
3). N/A 
This person does not discuss vaccines. 
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APPENDIX B: CONTENT ANALYSIS CODE SHEET 
1. Transcript I.D.: 
 
___________ 
 
2. Network: (Circle one) 
 
0). ABC 
 
1). CBS 
 
2). NBC 
 
3. Year of Story: 
 
_____________ 
 
4. Length of Story: (Circle one) 
 
0). 0 to 00:30 
 
1). 00:31 to 01:00 
 
2). 01:01 to 01:30 
 
3). 01:31 to 02:00 
 
4). 02:01 to 02:30 
 
5). 02:31 to 03:00 
 
6). 03:01 to 03:30 
 
7). 03:31 to 04:00 
 
8). 04:01 to 04:30 
 
9). 04:31 to 05:00 
 
10). Longer than 05:01 
 
 
5. Broadcast Placement: (Circle one) 
0). Lead story (defined as first story) 
 
1). Before the first commercial or lead 
story (first story) after the first commercial  
 
2). lead story (first story) after any other 
commercial 
 
3). Last story  
 
4). other (defined as placement anywhere 
not included in the above places) 
 
6. Topics Covered: causes/risk factors--
Does the story discuss or mention causes, 
risk factors, or potential causes or risk 
factors for autism? 
 
0). No 
 
1). Yes 
 
[If 1) Yes is circled, please continue 
with Question 6a. Otherwise, skip to 
Question 7.] 
 
6a. Topic Covered: Cause – were 
causes not included, mentioned, or 
main focus of story?  
 
0). Causes/risk factors were mentioned 
in the story, but not the main focus 
 
1). Causes/risk factors for autism are 
the main focus of the story 
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6b. Topic Covered: Cause – specific 
causes  
 
A). Genetics/Genes 
 0)   not included 
1)   mentioned 
 2)   primary focus of story 
 
If 1) mentioned or 2) primary focus of 
the story is circled, please circle one: 
 
0) story suggests that the cause or risk 
factor is unlikely  
1)  story suggests that the cause or risk   
     factor is likely 
2) story suggests that not enough is known 
or it is inconclusive as a cause or risk 
factor 
 
B). Brain/Neurological Irregularities 
 0)   not included 
1)   mentioned 
 2)   primary focus of story 
 
If 1) mentioned or 2) primary focus of 
the story is circled, please circle one: 
 
0) story suggests that the cause or risk 
factor is unlikely  
1) story suggests that the cause or risk 
factor is likely 
2) story suggests that not enough is known 
or it is inconclusive as a cause or risk 
factor 
 
C). Prenatal Exposure to Viruses 
 0)   not included 
1)   mentioned 
 2)   primary focus of story 
 
0) story suggests that the cause or risk 
factor is unlikely  
1) story suggests that the cause or risk 
factor is likely 
2) story suggests that not enough is known 
or it is inconclusive as a cause or risk 
factor 
 
D). Medications 
 0)   not included 
1)   mentioned 
 2)   primary focus of story 
 
If 1) mentioned or 2) primary focus of 
the story is circled, please circle one: 
 
0) story suggests that the cause or risk 
factor is unlikely  
1) story suggests that the cause or risk 
factor is likely 
2) story suggests that not enough is known 
or it is inconclusive as a cause or risk 
factor 
 
E). Vaccines 
 
 0)   not included 
1)   mentioned 
 2)   primary focus of story 
 
If 1) mentioned or 2) primary focus of 
the story is circled, please circle one: 
 
0) story suggests that the cause or risk 
factor is unlikely  
1) story suggests that the cause or risk 
factor is likely 
2) story suggests that not enough is known 
or it is inconclusive as a cause or risk 
factor 
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F). Environment 
 
 0)   not included 
1)   mentioned 
 2)   primary focus of story 
 
If 1) mentioned or 2) primary focus of 
the story is circled, please circle one: 
 
0) story suggests that the cause or risk 
factor is unlikely  
1) story suggests that the cause or risk 
factor is likely 
2) story suggests that not enough is known 
or it is inconclusive as a cause or risk 
factor 
G). Other: 
 
Write the cause in this space:  
________________ 
 
 0)   not included 
1)   mentioned 
 2)   primary focus of story 
 
If 1) mentioned or 2) primary focus of 
the story is circled, please circle one: 
 
0) story suggests that the cause or risk 
factor is unlikely  
1) story suggests that the cause or risk 
factor is likely 
2) story suggests that not enough is known 
or it is inconclusive as a cause or risk 
factor 
 
7. Topic Covered: Statistics/Prevalence-- 
Does the segment present statistics or 
estimates about the number of people 
with autism or the prevalence of 
autism?   
 
0). No 
1). Yes 
[If 1) Yes is circled, please continue 
with Question 7a. Otherwise, skip to 
Question 8.] 
 
7a. Topic Covered: 
Statistics/Prevalence– How many 
rates of autism are mentioned? 
 
___________________ 
 
 
7b. Topic Covered: 
Statistics/Prevalence– main focus of 
story or mention? 
 
0). Statistics/prevalence of autism was 
mentioned in the story, but not the main 
focus. 
 
1). Statistics/prevalence of autism was 
the main focus of the story. 
 
 
7c. Topic Covered: 
Statistic/Prevalence– what is (are) 
statistics/estimates or the prevalence 
number(s) given in the story? 
 
1. 4.5 per 10,000  
2. 67 per 10,000  
3. 60 per 10,000  
4. 1 in 166  
5. 1 in 150  
6. 1 in 90 or 1 in 91 
7. 1 in 110  
8. 1% or 1 percent  
9. other: please enter number 
mentioned_______________ 
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7d. Topic Covered: 
Statistics/Prevalence– does the story 
indicate whether the rates of people 
with autism or prevalence is 
increasing? 
 
0). No 
 
1). Yes 
 
8. Is autism identified as an “epidemic”? 
 
0). No 
 
1). Yes 
 
 
9. Is autism identified as an “urgent public 
health concern,” “public health 
concern,” or “public health problem” or 
“public health danger” or “public health 
concern”? 
 
0). No 
 
1). Yes 
 
10. Was anyone interviewed for the story? 
 
0). No 
 
1). Yes 
 
10a. Interviewed: Person 1 
1. Government Medical/Scientific 
Expert  
 
2. Medical Expert from a Hospital   
 
3. Medical Expert from an autism 
advocacy organization 
 
4. Medical Expert from a health care 
professional organization 
 
5. Person with autism 
6. Parents of or family member of a 
person with autism 
 
7. Celebrity 
If a celebrity is interviewed, please list 
that person’s name on the line below:  
_____________________________ 
 
8. Leader or someone associated with 
an advocacy organization. 
 
9. Other 
Please list any other identifying 
information for the first person 
interviewed that do(es) not fit into a 
category from above: 
_____________________________ 
 
10b. Interviewed: Person 2 
1. Government Medical/Scientific 
Expert  
 
2. Medical Expert from a Hospital   
 
3. Medical Expert from an autism 
advocacy organization 
 
4. Medical Expert from a health care 
professional organization 
 
5. Person with autism 
 
6. Parents of or family member of a 
person with autism 
 
7. Celebrity 
If a celebrity is interviewed, please list 
that person’s name on the line below:  
_____________________________ 
 
8. Leader or someone associated with 
an advocacy organization. 
 
9. Other 
Please list any other identifying 
information for the first person 
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 interviewed that do(es) not fit into a 
category from above: 
_____________________________ 
10c. Interviewed: Person 3 
 
1. Government Medical/Scientific 
Expert  
 
2. Medical Expert from a Hospital   
 
3. Medical Expert from an autism 
advocacy organization 
 
4. Medical Expert from a health care 
professional organization 
 
5. Person with autism 
 
6. Parents of or family member of a 
person with autism 
 
7. Celebrity 
If a celebrity is interviewed, please list 
that person’s name on the line below:  
_____________________________ 
 
8. Leader or someone associated with 
an advocacy organization. 
 
9. Other 
Please list any other identifying 
information for the first person 
interviewed that do(es) not fit into a 
category from above: 
_____________________________ 
 
10d. Interviewed: Person 4 
1. Government Medical/Scientific 
Expert  
 
2. Medical Expert from a Hospital   
 
3. Medical Expert from an autism 
advocacy organization 
 
4. Medical Expert from a health care 
6. Parents of or family member of a 
person with autism 
 
7. Celebrity 
If a celebrity is interviewed, please list 
that person’s name on the line below:  
_____________________________ 
 
8. Leader or someone associated with 
an advocacy organization. 
 
9. Other 
Please list any other identifying 
information for the first person 
interviewed that do(es) not fit into a 
category from above: 
_____________________________ 
 
10e. Interviewed: Person 5 
1. Government Medical/Scientific 
Expert  
 
2. Medical Expert from a Hospital   
 
3. Medical Expert from an autism 
advocacy organization 
 
4. Medical Expert from a health care 
professional organization 
 
5. Person with autism 
 
6. Parents of or family member of a 
person with autism 
 
7. Celebrity 
If a celebrity is interviewed, please list 
that person’s name on the line below:  
_____________________________ 
 
8. Leader or someone associated with 
an advocacy organization. 
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professional organization 
 
5. Person with autism 
 
9. Other 
Please list any other identifying 
information for the first person 
interviewed that do(es) not fit into a 
category from above: 
_____________________________ 
11. For each person interviewed, pro-link or 
anti-link (vaccines and autism) 
 
A). Person 1 
0). Anti-link  
 
1). Pro-link 
 
2). Not sure 
 
3). N/A (This person does not discuss 
vaccines) 
 
B). Person 2 
0). Anti-link 
 
1). Pro-link 
 
2). Not sure 
 
3). N/A (This person does not discuss 
vaccines) 
 
 
C). Person 3 
0). Anti-link  
 
1). Pro-link 
 
2). Not sure 
 
3). N/A (This person does not discuss 
vaccines) 
 
D). Person 4 
0). Anti-link  
 
1). Pro-link 
 
E). Person 5 
0). Anti-link  
 
1). Pro-link. 
 
2). Not sure 
 
3). N/A (This person does not discuss 
vaccines) 
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2). Not sure 
 
3). N/A (This person does not discuss 
vaccines) 
 
 
 
 
 
 
 
